Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3016724	p-hcyst	umol/l (umol/l)	2780	3833	0.03%
3016724	p-hcyst	— (—)	184	203	100.00%	Distribution not available
3016724	fp-hcyst	umol/l (umol/l)	101	105	0.00%
3016724	fp-hcyst	— (—)	18	18	100.00%	Distribution not available
3016724	homokysteiini	umol/l (umol/l)	11	14	0.00%	Distribution not available
3016724	s-hcyst	umol/l (umol/l)	9	11	0.00%	Distribution not available	Distribution not available
3016724	p-homokysteiini	umol/l (umol/l)	6	6	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Colitis, primary sclerosing, strict definition

159

167.38

319.97

1.9

1.3

11.19

10.69

umol/l

0.21

159

Colitis, primary sclerosing

198

162.00

307.65

1.9

1.3

11.09

10.40

umol/l

0.34

198

Cholangitis (primary sclerosing, PSC)

276

126

24.65

307.65

1.8

1.4

11.28

13.12

umol/l

1.85

276

118

IBD (strict) with PSC

166

218.66

307.65

1.9

1.4

11.17

10.00

umol/l

0.53

166

Ulcerative colitis (strict) with PSC

135

191.17

274.24

1.9

1.4

11.27

10.23

umol/l

0.42

135

Cerebrovascular diseases (FINNGEN)

426

541

5.75

199.47

1.3

1.4

11.77

10.94

umol/l

1.67

417

518

STROKE

570

1011

3.96

173.66

1.2

1.4

12.18

11.95

umol/l

0.34

555

964

Stroke, excluding SAH

484

963

3.78

141.84

1.2

1.5

12.39

13.50

umol/l

2.64

467

901

Ischaemic Stroke, excluding all haemorrhages

460

902

3.90

141.67

1.2

1.5

12.37

13.61

umol/l

3.09

446

840

Cerebrovascular diseases

577

1282

3.26

134.45

1.3

1.4

12.56

13.15

umol/l

1.07

557

1206

Stroke, including SAH

499

1052

3.55

133.72

1.2

1.5

12.34

13.51

umol/l

3.01

481

985

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

764

2032

2.72

130.38

1.5

1.4

13.31

11.69

umol/l

6.59

736

1922

Cardiovascular diseases (excluding rheumatic etc)

613

1121

3.19

128.74

1.4

11.78

10.10

umol/l

7.69

592

1058

Hard cardiovascular diseases

595

1316

2.93

112.64

1.3

1.4

13.16

12.65

umol/l

0.87

568

1251

IBD patients in KELA-register

278

633

4.48

111.57

1.8

1.3

10.95

12.02

umol/l

2.51

273

597

Mucosal proctocolitis

198

337

6.05

111.22

1.8

1.4

11.19

11.97

umol/l

1.00

198

314

Noninfective enteritis and colitis

427

1313

3.29

110.61

1.6

1.4

11.55

12.12

umol/l

1.06

419

1233

Inflammatory bowel disease

331

884

3.80

106.89

1.7

1.3

11.28

12.17

umol/l

1.91

325

838

Inflammatory bowel disease, strict (require KELA)

278

660

4.29

105.73

1.8

1.4

10.95

12.01

umol/l

2.52

273

625

Coagulation defects, purpura and other haemorrhagic conditions

228

474

4.92

102.48

1.4

1.5

12.13

12.32

umol/l

0.17

223

446

Cardiovascular diseases

534

988

2.97

98.26

1.4

11.41

10.01

umol/l

5.25

515

928

Any gastric operation

622

1149

2.73

96.60

1.5

1.2

11.97

11.16

umol/l

1.93

601

1077

GASTRO-related operations

622

1149

2.73

96.60

1.5

1.2

11.97

11.16

umol/l

1.93

601

1077

First line medication for Crohn's disease

823

1933

2.34

96.06

1.5

1.3

12.09

11.91

umol/l

0.31

794

1819

Venous thromboembolism

395

1304

2.97

85.81

1.3

1.4

12.94

12.91

umol/l

0.03

373

1230

DVT of lower extremities and pulmonary embolism

311

940

3.33

82.66

1.4

13.14

13.03

umol/l

0.09

294

886

Inflammatory bowel disease treatment related agents

807

2105

2.19

82.29

1.5

1.3

12.32

11.87

umol/l

0.98

778

1982

Pulmonary heart disease, diseases of pulmonary circulation

255

684

3.78

81.86

1.4

13.72

13.30

umol/l

0.37

240

641

Pulmonary embolism

239

628

3.86

79.07

1.4

1.5

13.38

13.23

umol/l

0.11

224

590

Pulmonary heart disease

239

630

3.84

78.71

1.4

1.5

13.38

13.21

umol/l

0.13

224

592

Malaise and fatigue

358

987

3.05

78.62

1.4

13.67

12.07

umol/l

2.88

332

933

Sequelae of cerebrovascular disease

251

587

3.80

78.39

1.3

1.5

12.53

14.04

umol/l

2.30

241

543

Disorders of gallbladder, biliary tract and pancreas

668

1906

2.27

76.85

1.5

1.3

12.40

12.22

umol/l

0.25

643

1808

ILD medications: immunosuppressive drugs

465

1756

2.56

76.00

1.5

1.4

13.07

11.79

umol/l

3.59

452

1664

Autoimmune diseases related-to ILD

597

2318

2.28

74.36

1.5

1.3

11.81

12.17

umol/l

0.67

582

2184

General symptoms and signs

760

1764

2.17

73.29

1.4

12.32

11.58

umol/l

1.99

716

1674

Reimbursement for rheumatic diseases

423

1623

2.62

73.24

1.6

1.4

11.82

12.16

umol/l

0.49

413

1537

Adjustment and management of implanted device

159

325

4.97

72.93

1.5

15.94

14.07

umol/l

1.91

154

298

Any reimbursement code in KELA

451

821

2.77

71.93

1.5

1.2

11.68

9.93

umol/l

6.69

426

793

Other heart diseases

380

883

2.87

70.30

1.5

1.4

13.36

10.44

umol/l

12.53

368

842

ILD medications

774

2058

2.08

68.53

1.4

12.40

11.78

umol/l

1.49

740

1945

Examination and observation for other reasons

445

1048

2.60

67.12

1.5

1.4

12.44

11.93

umol/l

0.66

420

1002

Heart failure,strict

334

824

2.95

66.69

1.5

1.4

16.38

12.92

umol/l

11.11

323

772

Cardiac arrhythmias

435

1135

2.55

64.73

1.5

1.4

13.09

10.63

umol/l

11.30

420

1090

Persons encountering health services for specific procedures and health care

718

2168

2.06

64.57

1.4

13.35

11.54

umol/l

7.97

684

2062

ILD medications: prednisolone, methylprednisolone, prednisone

733

2021

2.06

64.23

1.4

12.45

11.82

umol/l

1.45

699

1911

Autoimmune diseases excluding thyroid diseases

691

1835

2.10

63.40

1.5

1.3

12.26

12.25

umol/l

0.01

664

1728

Heart failure, not strict

474

1366

2.41

63.30

1.5

1.4

16.51

11.98

umol/l

24.52

457

1290

Atrial fibrillation and flutter

256

494

3.42

62.70

1.6

1.5

14.90

11.35

umol/l

10.54

246

474

Dental caries

233

696

3.36

62.60

1.4

14.21

12.00

umol/l

4.41

225

667

Autoimmune diseases excluding thyroid diseases, strict definition

670

1775

2.11

62.54

1.5

1.3

12.30

12.24

umol/l

0.08

643

1670

Used for control exclusion in common control thyroid runs

698

1706

2.08

61.25

1.5

1.3

11.89

12.26

umol/l

0.69

665

1609

Autoimmune diseases

733

1845

2.04

60.87

1.5

1.3

11.63

12.23

umol/l

1.55

703

1738

Transient ischemic attack

312

917

2.84

60.64

1.3

1.4

12.83

13.51

umol/l

0.79

303

853

Fever of other and unknown origin

357

1301

2.56

58.28

1.4

13.07

11.83

umol/l

2.52

347

1234

Heart failure, strict

341

916

2.70

58.08

1.5

1.4

16.35

13.39

umol/l

8.60

329

856

Condition for Implicit Sepsis (Organ dysfunction codes)

542

1822

2.17

57.96

1.5

1.4

14.33

11.93

umol/l

8.89

515

1731

Bacterial infection, other or unspecified

328

1118

2.67

57.68

1.4

13.92

12.53

umol/l

2.61

316

1048

Other neurological diseases

440

1521

2.34

57.36

1.3

1.4

12.57

12.88

umol/l

0.37

422

1433

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

337

784

2.75

57.22

1.3

1.4

11.73

10.43

umol/l

3.74

327

748

143

339

4.30

54.77

1.5

1.4

13.31

11.32

umol/l

2.66

137

328

Dentinal caries

199

597

3.36

53.65

1.4

14.49

12.08

umol/l

4.39

192

571

Diseases of liver

250

865

2.92

53.34

1.6

1.4

12.96

12.70

umol/l

0.22

239

818

Implicit Sepsis

451

1570

2.25

53.11

1.5

1.4

14.66

12.24

umol/l

7.73

427

1491

Implicit bacterial Sepsis

243

753

2.98

52.91

1.4

1.5

15.60

13.39

umol/l

3.42

232

706

Presence of cardiac and vascular implants and grafts

276

740

2.85

52.59

1.6

1.4

15.87

14.03

umol/l

3.16

266

688

Pacemaker

200

593

3.31

52.53

1.6

1.4

15.01

14.42

umol/l

0.49

195

548

Bacterial Sepsis

269

864

2.79

51.57

1.4

15.38

13.12

umol/l

3.96

255

813

Oral corticosteroids

650

2017

1.96

50.73

1.4

1.3

12.36

11.93

umol/l

0.82

624

1904

Ulcerative ileocolitis

109

7.16

49.43

1.9

1.5

10.50

11.55

umol/l

0.87

101

Other ulcerative colitis

150

5.99

48.48

1.7

1.5

11.25

11.74

umol/l

0.31

140

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

599

2083

1.96

48.40

1.5

1.4

13.93

11.64

umol/l

10.83

579

1973

Hypertensive diseases (excluding secondary)

356

855

2.44

46.71

1.4

13.27

10.41

umol/l

10.27

344

816

Atrial fibrillation and flutter with reimbursement

192

366

3.39

46.50

1.6

1.4

15.88

11.69

umol/l

9.18

184

351

Other heart diseases, wide

604

1939

1.94

46.31

1.5

1.4

13.26

11.24

umol/l

9.84

583

1840

Nonischemic cardiomyopathy

116

6.57

45.33

1.7

1.5

15.09

12.85

umol/l

1.76

106

Gastrointestinal diseases

414

915

2.28

45.06

1.5

1.3

11.76

10.95

umol/l

1.58

394

868

Diseases of arteries, arterioles and capillaries (FINNGEN)

175

357

3.46

44.86

1.4

1.5

13.90

11.55

umol/l

3.72

170

342

Nutritional anaemias

286

1151

2.43

42.51

1.5

1.4

13.93

12.43

umol/l

2.08

273

1085

All-cause Heart Failure

303

905

2.43

41.93

1.5

1.4

16.20

13.43

umol/l

6.84

291

846

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

263

488

2.72

40.92

1.5

1.3

11.77

10.90

umol/l

1.23

248

455

Symptoms and signs involving cognition, perception, emotional state and behaviour

565

2116

1.88

40.54

1.4

12.90

12.06

umol/l

1.70

532

2015

Anxiety disorders, excluding more controls

516

1768

1.94

40.44

1.4

11.22

11.95

umol/l

1.67

480

1714

Phlebitis and thrombophlebitis (not including DVT)

164

531

3.12

39.51

1.3

1.5

12.27

12.49

umol/l

0.16

158

496

Endocrine, nutritional and metabolic diseases

537

1417

1.94

39.03

1.4

12.22

11.18

umol/l

2.70

504

1362

Statin medication

469

1312

2.01

39.01

1.4

12.27

11.26

umol/l

2.51

454

1256

Other bacterial diseases

544

2018

1.87

38.48

1.4

14.21

11.88

umol/l

9.00

525

1905

Cardiodefibrillation

206

769

2.70

38.09

1.4

14.81

14.13

umol/l

0.67

195

720

Persons encountering health services for other counselling and medical advice, not elsewhere classified

657

2115

1.78

37.79

1.4

12.39

11.93

umol/l

0.89

618

2008

Persons encountering health services in other circumstances, wide

712

2124

1.75

37.66

1.4

12.64

11.93

umol/l

1.74

671

2017

Abnormalities of breathing

546

1753

1.86

36.57

1.4

13.09

11.56

umol/l

4.77

517

1661

Care involving use of rehabilitation procedures

365

1685

2.07

36.54

1.3

1.4

12.69

11.88

umol/l

1.43

350

1598

Use of pramipexole

146

465

3.17

36.21

1.8

1.4

14.00

12.76

umol/l

1.10

140

438

Other pulmonary heart/vessel disease

7.07

36.16

1.6

1.5

15.35

15.84

umol/l

0.14

Medical observation and evaluation for suspected diseases and conditions

423

1062

2.05

36.01

1.4

12.35

11.98

umol/l

0.47

396

1015

Extrapyramidal and movement disorders

212

828

2.58

35.95

1.8

1.4

14.63

12.73

umol/l

2.93

206

774

Neurotic, stress-related and somatoform disorders

548

2170

1.80

34.69

1.4

11.09

11.93

umol/l

2.30

508

2077

Anxiety disorders

552

2185

1.80

34.62

1.4

11.09

11.95

umol/l

2.38

512

2092

Certain infectious and parasitic diseases

598

1677

1.79

34.30

1.4

1.3

12.57

11.51

umol/l

2.95

566

1585

Other diseases of intestines

633

2132

1.73

33.56

1.4

12.16

11.82

umol/l

0.59

598

2030

Neurological diseases, wide definition

241

476

2.56

33.55

1.4

11.02

10.87

umol/l

0.13

228

448

Heart failure and bmi 25plus

186

470

2.75

32.70

1.4

17.03

13.78

umol/l

5.59

177

439

Metabolic disorders

533

1847

1.80

32.66

1.4

13.07

11.96

umol/l

2.83

505

1755

Mood disorders, excluding more controls

543

1851

1.79

32.66

1.3

1.4

11.97

12.10

umol/l

0.16

498

1789

Iron deficiency anaemia

231

974

2.36

32.48

1.4

13.76

12.28

umol/l

1.72

220

923

Neurological diseases

531

1475

1.82

32.05

1.4

11.68

11.60

umol/l

0.09

504

1406

Second line medication for Crohn's disease

342

1712

2.01

31.99

1.4

12.68

11.83

umol/l

1.57

334

1626

Symptoms and signs involving the circulatory and respiratory systems

611

1768

1.74

31.72

1.4

12.04

11.56

umol/l

0.88

583

1674

Chronic periodontitis

114

343

3.37

31.14

1.4

1.5

15.44

13.11

umol/l

2.55

108

326

Other anaemias

215

873

2.39

30.90

1.6

1.4

15.57

13.14

umol/l

3.64

205

812

Anxiety (asthma-related co-morbidities)

383

1569

1.93

30.85

1.4

10.93

11.42

umol/l

0.82

351

1521

Continuous positive airway pressure

119

312

3.32

30.71

1.4

1.5

13.84

11.63

umol/l

2.57

114

307

Other and unspecified anaemias

212

861

2.40

30.66

1.6

1.4

15.67

13.18

umol/l

3.72

202

801

Headache

366

1575

1.95

30.59

1.4

11.43

umol/l

0.00

344

1497

Tramadol

456

1597

1.84

30.45

1.4

12.98

11.78

umol/l

3.06

434

1519

Diseases of pulp and periapical tissues

224

970

2.33

30.42

1.4

13.50

11.77

umol/l

3.40

214

928

Dyspnoea

485

2086

1.79

30.40

1.5

1.4

14.02

11.91

umol/l

6.64

465

1976

Mood disorders

595

2307

1.70

30.38

1.3

1.4

11.71

12.03

umol/l

0.55

547

2209

Mood [affective] disorders

594

2308

1.70

30.26

1.3

1.4

11.70

12.03

umol/l

0.57

546

2211

Aplastic and other anaemias

229

948

2.30

30.17

1.6

1.4

15.68

13.16

umol/l

4.07

219

885

Intestinal infectious diseases

533

2403

1.73

30.10

1.4

12.47

11.97

umol/l

0.85

505

2278

Other and unspecified iron deficiency

185

744

2.50

29.60

1.4

13.58

12.25

umol/l

1.17

175

704

Antihypertensive medication - note that there are other indications

411

1181

1.91

29.55

1.4

11.88

10.11

umol/l

5.81

389

1132

Complications of procedures, not elsewhere classified

441

2116

1.81

29.36

1.4

12.28

12.06

umol/l

0.30

420

2007

Complications of surgical and medical care, not elsewhere classified

535

2232

1.73

29.33

1.4

12.60

12.08

umol/l

0.93

511

2116

All anxiety disorders

387

1664

1.88

28.83

1.4

10.91

11.46

umol/l

1.01

355

1599

Arterial embolism and thrombosis

5.82

28.51

1.5

1.6

13.80

14.07

umol/l

0.08

Dizziness and giddiness

394

1727

1.86

28.41

1.4

13.05

12.31

umol/l

1.01

373

1636

Other diseases of liver

126

426

2.99

28.33

1.6

1.5

12.34

12.42

umol/l

0.04

120

404

Other soft tissue disorders, not elsewhere classified

535

1932

1.72

28.00

1.4

11.92

12.01

umol/l

0.10

511

1833

Implicit viral Sepsis

126

429

2.97

27.97

1.4

14.58

12.48

umol/l

2.30

119

404

Viral Sepsis

126

430

2.96

27.85

1.4

14.58

12.48

umol/l

2.30

119

405

L04AX Other immunosuppressants

322

1662

1.95

27.67

1.4

12.82

11.89

umol/l

1.71

314

1577

Depression

550

2255

1.69

27.52

1.3

1.4

11.60

11.97

umol/l

0.63

505

2160

Pain in throat and chest

478

1662

1.76

27.46

1.4

12.17

11.70

umol/l

0.72

452

1572

Episodal and paroxysmal disorders

628

1955

1.65

27.32

1.4

11.72

11.98

umol/l

0.40

595

1858

Non-ischemic cardiomyopathy

158

493

2.65

27.23

1.5

1.4

14.88

13.34

umol/l

1.88

151

459

Opioids

575

1811

1.67

26.42

1.4

12.23

11.57

umol/l

1.45

553

1712

Other anxiety disorders

289

1288

2.00

26.32

1.3

1.4

10.93

11.41

umol/l

0.67

267

1240

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

518

1995

1.70

26.31

1.4

12.48

12.30

umol/l

0.26

498

1891

Psychiatric diseases

608

1855

1.65

26.05

1.4

12.05

12.07

umol/l

0.02

561

1797

Infections, IBD-co-morbidities

107

239

3.29

26.02

1.5

14.42

11.67

umol/l

2.49

102

226

Syncope and collapse

225

918

2.18

25.81

1.3

1.4

14.08

12.34

umol/l

2.59

210

867

Pain in limb

440

1821

1.75

25.70

1.4

12.57

12.06

umol/l

0.77

421

1730

Congenital malformations, deformations and chromosomal abnormalities

359

1882

1.84

25.62

1.3

1.4

10.71

11.54

umol/l

2.03

344

1786

Diarrhoea and gastroenteritis of presumed infectious origin

399

2043

1.78

25.60

1.5

1.4

12.52

11.83

umol/l

1.10

376

1943

Other arrhythmias

350

1439

1.87

25.48

1.4

12.91

11.61

umol/l

3.03

338

1370

Chronic periapical parodontitis

135

504

2.70

25.28

1.5

14.38

12.51

umol/l

2.14

130

483

Bleeding

419

1733

1.77

25.07

1.4

13.60

12.59

umol/l

1.91

402

1640

Complications of medical and surgical care

381

2028

1.79

25.06

1.4

12.30

12.28

umol/l

0.01

364

1920

Exposure to unspecified factor

528

2505

1.64

24.48

1.4

12.13

12.01

umol/l

0.15

497

2381

Hypothyroidism, strict autoimmune

370

1346

1.83

24.34

1.5

1.3

10.83

12.32

umol/l

3.88

353

1268

Migraine

286

1254

1.95

24.08

1.3

1.4

10.46

11.02

umol/l

0.77

272

1198

Any mental disorder

607

1891

1.61

24.01

1.4

11.99

12.14

umol/l

0.20

561

1826

Total colectomy

107

4.99

24.00

1.6

1.5

11.84

12.16

umol/l

0.14

100

Total colectomy operation

107

4.99

24.00

1.6

1.5

11.84

12.16

umol/l

0.14

100

Hypertensive diseases

456

1509

1.72

23.51

1.4

13.57

11.29

umol/l

8.60

436

1439

Disorders of the thyroid gland

500

1977

1.66

23.43

1.4

1.3

11.23

12.42

umol/l

3.53

479

1876

Deposits [accretions] on teeth

178

3.87

23.28

1.5

14.69

10.99

umol/l

2.67

171

Other antidepressants

567

1834

1.62

23.00

1.4

11.68

12.45

umol/l

2.02

528

1756

Oedema, not elsewhere classified

156

650

2.40

22.96

1.4

13.16

12.14

umol/l

0.86

147

614

Symptoms and signs involving the digestive system and abdomen

561

1736

1.62

22.89

1.5

1.3

12.28

12.13

umol/l

0.19

534

1642

Hypertension

453

1509

1.70

22.81

1.4

13.57

11.29

umol/l

8.61

433

1439

Renal tubulo-interstitial diseases

441

2013

1.69

22.67

1.4

15.71

11.62

umol/l

18.41

428

1904

Influenza and pneumonia

573

2382

1.59

22.54

1.4

13.55

11.56

umol/l

7.92

538

2265

Benign neoplasm: Colon

243

1199

1.99

22.45

1.4

13.80

13.42

umol/l

0.30

229

1129

Visual disturbances and blindness

269

1415

1.91

22.00

1.3

1.4

11.72

12.38

umol/l

0.84

260

1336

Abnormal findings on examination of blood, without diagnosis

235

1100

2.01

22.00

1.5

1.4

12.85

13.34

umol/l

0.49

225

1032

Disturbances of skin sensation

174

781

2.24

21.90

1.3

1.4

11.00

11.57

umol/l

0.59

167

748

Diseases of arteries, arterioles and capillaries

310

1255

1.85

21.84

1.4

13.73

13.29

umol/l

0.45

291

1184

Other symptoms and signs involving cognitive functions and awareness

208

938

2.09

21.70

1.3

1.4

12.94

13.08

umol/l

0.10

193

880

Benign neoplasm of colon, rectum, anus and anal canal

282

1361

1.88

21.54

1.4

13.66

13.29

umol/l

0.32

265

1286

Other functional intestinal disorders

226

1073

2.01

21.43

1.5

1.4

12.43

12.33

umol/l

0.07

217

1020

Disorders of lipoprotein metabolism and other lipidaemias

406

1494

1.71

21.41

1.3

1.4

13.46

12.43

umol/l

1.85

380

1418

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

484

1861

1.63

21.35

1.4

13.63

11.59

umol/l

6.65

453

1763

484

1861

1.63

21.35

1.4

13.63

11.59

umol/l

6.65

453

1763

Visual disturbances

254

1325

1.93

21.33

1.3

1.4

11.65

12.29

umol/l

0.77

246

1254

Benign neoplasm: Colon

238

918

2.00

21.10

1.4

13.71

13.24

umol/l

0.39

224

866

Pain (limb, back, neck, head abdominally)

417

1222

1.71

20.92

1.5

1.3

12.76

12.10

umol/l

0.98

400

1146

Hypothyroidism, other/unspecified

458

1846

1.64

20.83

1.5

1.3

10.88

12.33

umol/l

4.62

439

1752

Recurrent or chronic depression

252

936

1.95

20.80

1.3

1.4

11.45

11.82

umol/l

0.39

239

913

Pneumonia, organism unspecified

476

2134

1.62

20.75

1.4

13.89

11.75

umol/l

6.86

443

2035

Persons encountering health services for examination and investigation

373

1062

1.77

20.73

1.5

1.4

12.70

11.98

umol/l

1.10

347

1015

Abdominal and pelvic pain

548

1736

1.59

20.69

1.5

1.3

12.09

12.13

umol/l

0.05

522

1642

Direct fill therapy

105

384

2.77

20.59

1.4

1.5

14.38

11.89

umol/l

2.47

100

367

Diseases of oesophagus, stomach and duodenum

559

2177

1.56

20.47

1.4

12.65

11.91

umol/l

1.61

525

2075

Cholelithiasis, broad definition with cholecystitis

418

1720

1.67

20.45

1.4

12.98

12.19

umol/l

1.21

398

1629

Symptoms and signs involving the skin and subcutaneous tissue

354

2058

1.72

20.45

1.4

11.50

12.13

umol/l

1.08

344

1948

Diseases of the eye and adnexa

498

1542

1.62

20.33

1.4

11.65

11.82

umol/l

0.21

471

1471

Pain, not elsewhere classified

152

667

2.29

20.22

1.3

1.4

12.06

11.68

umol/l

0.28

142

639

Benign neoplasm of colon, rectum, anus and anal canal

268

1018

1.89

19.99

1.4

13.53

13.06

umol/l

0.42

252

964

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

299

1674

1.79

19.81

1.4

12.32

12.39

umol/l

0.06

287

1584

Abnormalities of heart beat

186

884

2.10

19.80

1.4

11.74

11.96

umol/l

0.20

181

833

Hypothyreosis and Thyroxine purchase for inclusion criteria

469

1932

1.61

19.58

1.5

1.3

10.88

12.32

umol/l

4.78

450

1831

All pneumoniae

532

2367

1.56

19.51

1.4

13.71

11.64

umol/l

7.65

498

2252

Pneumonias (Asthma/COPD co-morbidities)

528

2357

1.56

19.42

1.4

13.73

11.67

umol/l

7.45

493

2242

Haemorrhage from respiratory passages

165

706

2.18

19.21

1.5

1.4

13.96

12.95

umol/l

0.91

159

663

Oxycodone

169

764

2.15

19.16

1.3

1.4

13.11

12.88

umol/l

0.15

159

716

Other reaction to severe stress, and adjustment disorders

219

1130

1.95

19.07

1.4

11.29

11.37

umol/l

0.06

204

1087

Depression or dysthymia

378

1251

1.70

18.80

1.3

1.4

12.48

12.43

umol/l

0.04

358

1210

Cholelithiasis

395

1680

1.65

18.74

1.4

12.95

12.17

umol/l

1.12

375

1589

Special screening examination for infectious and parasitic diseases

168

583

2.17

18.44

1.3

10.59

10.93

umol/l

0.30

153

562

General examination and investigation of persons without complaint and reported diagnosis

344

1059

1.73

18.32

1.5

1.4

12.04

11.93

umol/l

0.11

327

1012

Hypertension, essential

415

1449

1.64

18.26

1.4

13.21

11.39

umol/l

5.97

396

1380

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

509

2327

1.54

18.03

1.4

13.79

11.69

umol/l

7.26

476

2210

Septicaemia

186

887

2.03

18.03

1.4

14.44

12.78

umol/l

2.15

178

829

Nonpyogenic thrombosis of intracranial venous system

12.63

17.94

2.4

1.9

11.77

11.97

umol/l

0.03

Subjective visual disturbances

140

630

2.24

17.63

1.4

1.5

11.90

12.31

umol/l

0.24

135

593

Pain in joint

307

1170

1.74

17.49

1.4

1.3

11.85

12.02

umol/l

0.17

290

1101

Neoplasms

458

1551

1.59

17.48

1.4

11.53

11.69

umol/l

0.19

438

1471

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

278

1589

1.76

17.44

1.4

12.20

12.40

umol/l

0.21

266

1507

Explicit Sepsis

195

956

1.96

17.35

1.4

14.23

12.58

umol/l

2.21

186

903

Asthma, excluding more controls

410

1348

1.63

17.25

1.3

1.4

12.23

11.13

umol/l

2.30

393

1280

Codes for special purposes

245

1360

1.81

17.04

1.5

1.4

12.92

11.57

umol/l

2.21

236

1295

Persons encountering health services for specific procedures, not carried out

190

3.31

16.67

1.1

1.5

13.56

11.12

umol/l

1.26

181

Ulcer of lower limb, not elsewhere classified

268

2.90

16.63

1.3

1.5

16.86

13.85

umol/l

2.28

251

Provisional assignment of new diseases of uncertain etiology

243

1359

1.80

16.50

1.5

1.4

12.97

11.57

umol/l

2.33

234

1294

Hyperlipidaemia, other/unspecified

166

773

2.04

16.46

1.3

1.4

13.90

13.43

umol/l

0.34

160

725

Nausea and vomiting

134

606

2.19

15.98

1.4

13.53

12.18

umol/l

0.94

128

565

Other diseases of blood and blood-forming organs, wide

121

536

2.27

15.88

1.4

12.96

12.85

umol/l

0.05

116

507

Migraine with aura

142

671

2.13

15.87

1.3

1.4

10.90

10.88

umol/l

0.01

135

641

Polyneuropathies and other disorders of the peripheral nervous system

116

506

2.31

15.79

1.2

1.5

14.38

13.21

umol/l

0.65

105

479

Gout, unspecified

399

2.47

15.57

1.2

1.4

18.08

14.33

umol/l

3.47

369

Other medical care

176

883

1.95

15.56

1.3

1.4

13.33

12.72

umol/l

0.47

165

827

Constipation

409

1884

1.56

15.41

1.4

12.36

12.45

umol/l

0.09

385

1786

Chronic periodontitis, complicated

226

3.00

15.37

1.4

1.5

15.08

13.48

umol/l

1.08

214

Pure hypercholesterolaemia

328

1342

1.64

15.23

1.3

1.4

13.97

12.67

umol/l

1.96

306

1272

Symptoms and signs involving speech and voice

164

835

1.97

14.99

1.4

12.07

12.41

umol/l

0.26

156

790

Other disorders of fluid, electrolyte and acid-base balance

132

597

2.14

14.96

1.3

1.4

15.10

13.31

umol/l

1.45

124

558

Unspecified jaundice

4.21

14.87

1.7

1.4

11.69

14.26

umol/l

1.67

Codeine

485

1776

1.50

14.79

1.3

1.4

12.51

11.56

umol/l

2.01

460

1679

COPD/asthma related infections

546

1864

1.47

14.60

1.4

12.68

11.59

umol/l

2.88

510

1766

COPD/asthma/ILD related infections

546

1864

1.47

14.60

1.4

12.68

11.59

umol/l

2.88

510

1766

Asthma

416

1445

1.55

14.41

1.3

1.4

12.27

11.48

umol/l

1.39

399

1371

Autoimmune hepatitis

13.35

14.36

1.6

2.0

10.14

10.56

umol/l

0.12

Irritable bowel syndrome

145

718

2.03

14.36

1.3

1.4

10.83

11.56

umol/l

0.71

132

685

Other disorders of skin and subcutaneous tissue

310

1760

1.62

14.29

1.4

13.23

12.43

umol/l

1.13

296

1663

Parasetamol

452

1521

1.52

14.28

1.4

12.65

11.36

umol/l

3.36

426

1441

Benign neoplasms

427

1582

1.53

14.24

1.4

11.90

11.79

umol/l

0.12

410

1501

Symptoms and signs involving the nervous and musculoskeletal systems

274

1654

1.66

14.19

1.3

1.4

13.48

12.08

umol/l

2.17

256

1571

Gout, idiopatic and unspecified

112

505

2.23

14.14

1.3

1.4

17.50

14.14

umol/l

3.53

101

468

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

171

902

1.91

14.11

1.4

11.88

11.84

umol/l

0.02

166

859

Other special examinations and investigations of persons without complaint or reported diagnosis

339

1062

1.62

14.01

1.4

12.28

11.98

umol/l

0.33

319

1015

Sleep disorders (combined)

489

2183

1.47

13.91

1.4

12.33

12.08

umol/l

0.32

462

2071

Diseases of the digestive system

206

1155

1.79

13.86

1.4

13.24

12.97

umol/l

0.21

201

1087

Gout

128

556

2.11

13.83

1.3

1.5

17.11

14.28

umol/l

3.09

116

526

Heart failure and coronary heart disease

130

458

2.13

13.77

1.4

18.21

14.82

umol/l

3.18

125

422

Factors influencing health status and contact with health services

174

444

1.97

13.75

1.6

1.3

12.93

11.54

umol/l

1.75

164

422

Other and unspecified polyneuropathies, also in other diseases

100

436

2.31

13.71

1.3

1.5

14.44

13.57

umol/l

0.41

411

Chronic gastritis

128

618

2.08

13.59

1.4

13.97

13.31

umol/l

0.33

118

581

Peripheral artery disease

177

760

1.88

13.59

1.4

15.00

14.17

umol/l

0.66

167

715

Gout, FINNGEN

128

620

2.08

13.49

1.3

1.4

17.11

14.37

umol/l

2.97

116

583

Other disorders of urethra and urinary system

327

1554

1.58

13.30

1.4

1.3

12.43

11.88

umol/l

0.66

306

1475

Cystitis

412

1668

1.51

13.29

1.4

1.3

11.68

11.85

umol/l

0.19

385

1587

Behavioural syndromes associated with physiological disturbances and physical factors

179

980

1.83

13.16

1.4

10.61

11.34

umol/l

0.67

168

936

Benzodiazepine use

488

2398

1.45

13.15

1.5

1.4

12.27

12.10

umol/l

0.19

450

2287

Osteopathies and chondropathies

254

1455

1.66

13.10

1.5

1.4

13.52

12.30

umol/l

1.64

240

1384

Other disorders of teeth and supporting structures

110

512

2.16

12.89

1.4

1.5

14.02

12.42

umol/l

1.81

103

487

Chronic hepatitis NAS

7.76

12.78

1.7

1.8

11.50

11.52

umol/l

0.01

Asthma (only as main-diagnosis), excluding more controls

351

1348

1.56

12.76

1.4

12.02

11.13

umol/l

1.64

338

1280

Other pulmonary diagnosis

434

1457

1.50

12.71

1.4

12.75

11.47

umol/l

3.01

412

1382

Abnormal serum enzyme levels

138

694

1.97

12.65

1.5

1.4

13.02

14.08

umol/l

0.99

130

646

Selective serotonin reuptake inhibitors

506

1847

1.45

12.63

1.3

1.4

11.67

12.43

umol/l

1.71

470

1769

Other external causes of accidental injury

452

1533

1.48

12.60

1.4

12.40

11.60

umol/l

1.52

424

1468

Covid-19 confirmed case

145

754

1.93

12.55

1.5

1.4

13.42

12.18

umol/l

1.43

137

715

Asthma (mode)

398

1451

1.51

12.47

1.3

1.4

12.22

11.49

umol/l

1.20

382

1377

Coronary atherosclerosis

290

1164

1.61

12.44

1.5

1.4

15.17

13.00

umol/l

4.49

271

1105

Excluding asthma or asthma-COPD overlap

432

1457

1.49

12.39

1.4

12.87

11.47

umol/l

3.42

410

1382

Fall on same level

587

2354

1.40

12.25

1.4

13.16

11.59

umol/l

5.57

549

2243

Ischaemic heart disease, wide definition

340

1383

1.54

12.08

1.6

1.4

15.07

12.67

umol/l

5.95

317

1315

ILD differential diagnosis

428

1451

1.48

11.99

1.4

12.85

11.49

umol/l

3.28

406

1377

COPD differential diagnosis

427

1452

1.48

11.79

1.4

12.87

11.48

umol/l

3.34

405

1378

Other disorders of veins

176

994

1.78

11.72

1.4

12.66

11.91

umol/l

0.75

171

935

Ischemic heart diseases

345

1420

1.53

11.67

1.6

1.4

14.92

12.62

umol/l

5.75

322

1352

Other diseases of urinary system

489

1931

1.43

11.65

1.4

12.11

12.01

umol/l

0.12

460

1840

Asthma, unspecified (mode), excluding more controls

243

1167

1.64

11.64

1.3

1.4

12.86

11.17

umol/l

3.01

234

1114

Temporomandibular joint disorders

391

2.26

11.61

1.5

1.3

10.79

11.07

umol/l

0.17

368

Gout, strict definition

342

2.35

11.55

1.3

1.4

16.90

14.80

umol/l

1.44

317

Intestinal stricture

133

693

1.93

11.49

1.4

14.31

13.10

umol/l

0.92

128

647

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

440

1800

1.45

11.43

1.3

1.4

11.64

12.08

umol/l

0.70

427

1712

Malignant neoplasm, wide definition for exclusion

440

1801

1.45

11.40

1.3

1.4

11.64

12.08

umol/l

0.70

427

1713

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

440

1801

1.45

11.39

1.3

1.4

11.64

12.08

umol/l

0.70

427

1713

Other diseases of anus and rectum

129

667

1.94

11.37

1.3

1.4

13.38

12.71

umol/l

0.45

122

629

Obesity related asthma

162

903

1.80

11.33

1.3

1.4

13.79

12.13

umol/l

1.82

152

857

Erysipelas

229

1276

1.64

11.32

1.4

15.30

12.73

umol/l

4.59

220

1199

Cardiac arrest

3.84

11.10

1.9

1.4

14.52

12.75

umol/l

0.78

Atherosclerosis, excluding cerebral and coronary sclerosis

156

684

1.83

11.06

1.3

1.4

15.07

14.27

umol/l

0.53

150

641

556

2123

1.39

11.06

1.4

12.61

11.92

umol/l

1.45

531

2002

Benign neoplasm of other and ill-defined parts of digestive system

351

2.29

10.90

1.4

1.5

12.53

13.30

umol/l

0.41

328

Other headache syndromes

198

1186

1.68

10.74

1.3

1.4

10.72

11.74

umol/l

1.78

186

1129

Procreative management

183

901

1.72

10.66

1.6

1.4

10.40

11.42

umol/l

1.98

177

855

Accidents

439

1533

1.44

10.64

1.4

12.59

11.60

umol/l

2.06

414

1468

Hypothyroidism, strict autoimmune, 3 medication purchases required

386

1812

1.46

10.63

1.5

1.3

10.74

12.24

umol/l

4.40

370

1716

Falls/tendency to fall

572

2092

1.37

10.61

1.4

12.63

11.54

umol/l

3.24

540

1995

6-mercaptopurine

4.29

10.59

1.5

10.49

10.85

umol/l

0.13

Speech therapy

125

664

1.89

10.25

1.3

1.4

12.51

12.61

umol/l

0.06

116

626

Asthma (only as main-diagnosis)

352

1445

1.47

10.09

1.4

12.05

11.48

umol/l

0.85

339

1371

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

117

556

1.93

9.97

1.3

1.4

10.11

10.48

umol/l

0.36

111

526

Benign neoplasms

494

1998

1.38

9.89

1.4

12.08

12.00

umol/l

0.10

472

1898

Codeine or tramadol medication

553

2260

1.36

9.87

1.3

1.4

12.51

11.87

umol/l

1.24

524

2143

Diaphragmatic hernia

152

869

1.76

9.82

1.5

1.4

13.61

12.80

umol/l

0.67

141

825

Asthma, unspecified (mode)

245

1244

1.57

9.80

1.3

1.4

12.98

11.55

umol/l

2.26

236

1185

Follow-up examination after treatment for conditions other than malignant neoplasms

204

813

1.65

9.75

1.3

11.90

11.97

umol/l

0.05

191

780

Soft tissue disorders

523

1992

1.37

9.60

1.4

11.67

12.01

umol/l

0.55

506

1883

Diseases of oral cavity, salivary glands and jaws

446

1633

1.40

9.60

1.4

12.57

11.84

umol/l

1.35

421

1553

Benign neoplasm: Colon, unspecified

482

2.01

9.55

1.4

1.5

13.95

13.80

umol/l

0.06

449

Other nutritional deficiencies

303

2012

1.48

9.50

1.3

1.4

12.71

11.55

umol/l

1.99

271

1923

Injuries to the head

521

2509

1.35

9.48

1.4

12.99

11.85

umol/l

2.83

488

2387

Sleep apnoea

421

2043

1.40

9.44

1.4

12.58

12.27

umol/l

0.42

399

1942

Dentofacial anomalies [including malocclusion]

145

820

1.76

9.38

1.4

11.48

10.83

umol/l

0.65

137

785

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

259

1583

1.52

9.33

1.4

13.82

12.86

umol/l

1.13

245

1497

Disorders of other endocrine glands

199

1219

1.61

9.32

1.5

1.4

11.86

11.88

umol/l

0.01

193

1160

Intracranial trauma

244

1180

1.55

9.26

1.4

11.62

11.71

umol/l

0.09

233

1125

Malignant neoplasm

421

1788

1.40

9.19

1.3

1.4

11.68

12.23

umol/l

0.94

408

1697

Somatoform disorder

439

2.04

9.11

1.2

1.4

9.83

12.06

umol/l

4.26

422

Nonorganic sleeping disorders, excluding more controls

460

2.01

9.07

1.4

10.83

11.76

umol/l

0.48

445

Functional dyspepsia

123

678

1.82

9.04

1.4

12.17

12.12

umol/l

0.02

117

644

Other general symptoms and signs

105

3.24

9.00

1.4

1.5

10.02

10.97

umol/l

0.46

Other aneurysm

3.41

8.91

1.4

1.5

11.60

13.64

umol/l

1.18

Other and unspecified immunodeficiencies with predominantly antibody defects

7.41

8.89

1.6

1.8

10.58

10.81

umol/l

0.05

Diverticular disease of intestine

287

1284

1.49

8.88

1.4

14.13

12.82

umol/l

1.94

273

1218

Major coronary heart disease event excluding revascularizations

251

1137

1.53

8.86

1.5

1.4

15.64

13.34

umol/l

3.69

229

1077

Diseases of the skin and subcutaneous tissue

505

1871

1.36

8.83

1.3

1.4

12.55

11.90

umol/l

1.19

474

1780

Voice disturbances

119

657

1.82

8.72

1.4

12.23

12.57

umol/l

0.22

112

621

Cholecystectomy

296

1804

1.45

8.55

1.4

13.31

12.22

umol/l

1.36

279

1713

Dermatitis and eczema

511

2514

1.33

8.50

1.3

1.4

11.71

12.11

umol/l

0.71

479

2389

Myocardial infarction

196

883

1.60

8.49

1.4

16.19

13.47

umol/l

3.73

178

834

Personality disorders, excluding more controls

130

743

1.76

8.49

1.3

1.4

12.04

11.57

umol/l

0.28

114

725

External causes of morbidity and mortality

351

1231

1.43

8.46

1.4

12.25

11.45

umol/l

1.31

330

1176

Other complications of surgical and medical care, not elsewhere classified

218

2.45

8.45

1.4

1.5

12.68

11.70

umol/l

0.48

208

Type 2 diabetes, wide definition

338

1550

1.42

8.35

1.4

14.50

12.28

umol/l

5.51

310

1488

Obsessive-compulsive disorder

178

2.61

8.34

1.2

1.6

10.14

10.90

umol/l

0.48

171

Valvular heart disease excluding rheumatic fever

184

836

1.61

8.31

1.4

14.91

12.41

umol/l

4.10

179

790

Bronchitis

493

2424

1.34

8.27

1.3

1.4

12.80

11.89

umol/l

2.27

474

2288

Viral infections characterized by skin and mucous membrane lesions

191

1215

1.58

8.24

1.3

1.4

12.98

12.01

umol/l

1.12

179

1156

Other diseases of pericardium

3.72

8.18

1.4

15.03

12.33

umol/l

0.99

Asthma, hospital admission 2, infections

257

1717

1.48

8.17

1.3

1.4

12.70

12.00

umol/l

0.84

247

1624

Asthma-related infections

257

1717

1.48

8.17

1.3

1.4

12.70

12.00

umol/l

0.84

247

1624

Cough

174

1041

1.61

8.14

1.4

11.51

11.97

umol/l

0.50

166

985

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

317

2.16

8.13

1.5

14.59

13.75

umol/l

0.35

299

Immunodeficiencies

119

2.98

8.10

1.3

1.5

11.17

11.30

umol/l

0.04

110

Generalized anxiety disorder

425

1.99

8.07

1.5

9.43

11.19

umol/l

2.91

409

Migraine without aura

107

587

1.83

8.05

1.3

1.4

10.18

10.58

umol/l

0.22

101

565

Chronic pancreatitis

267

2.26

8.04

1.3

1.4

13.08

13.47

umol/l

0.15

249

Diseases of the musculoskeletal system and connective tissue

311

1079

1.45

8.03

1.4

11.76

11.54

umol/l

0.21

294

1015

Benign neoplasm of other and ill-defined parts of digestive system

399

2.02

8.00

1.4

12.53

12.97

umol/l

0.21

377

Non-rheumatic valve diseases

181

828

1.60

7.94

1.4

14.97

12.44

umol/l

4.07

176

782

Myocardial infarction, strict

181

828

1.60

7.94

1.5

1.4

16.52

13.57

umol/l

3.95

163

781

Retinal detachments and breaks

139

826

1.69

7.92

1.5

1.4

12.46

13.38

umol/l

0.80

129

777

Other gastritis (incl. Duodenitis)

100

540

1.86

7.91

1.4

13.86

13.07

umol/l

0.48

507

Myalgia

110

612

1.81

7.91

1.4

10.90

11.83

umol/l

0.97

105

580

Dysphagia

534

1.86

7.86

1.4

1.3

12.06

12.94

umol/l

0.60

502

205

1330

1.53

7.85

1.3

1.4

12.39

11.70

umol/l

0.71

198

1268

Major coronary heart disease event

273

1249

1.46

7.80

1.5

1.4

15.59

13.24

umol/l

4.68

251

1183

Organic, including symptomatic, mental disorders

171

767

1.61

7.77

1.7

1.4

14.21

14.12

umol/l

0.05

158

709

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

160

867

1.63

7.74

1.3

1.5

13.14

13.32

umol/l

0.11

153

816

Phobic anxiety disorders

377

2.03

7.73

1.4

1.5

11.54

11.31

umol/l

0.10

361

Other diseases of hard tissues of teeth

301

1577

1.43

7.71

1.4

11.95

11.60

umol/l

0.41

286

1500

Disorders of conjunctiva

380

2333

1.37

7.70

1.4

10.90

11.88

umol/l

2.22

360

2213

Sleep apnoea, including avohilmo

438

2118

1.34

7.69

1.4

12.37

12.19

umol/l

0.22

414

2009

Conjunctivitis

350

2211

1.38

7.66

1.4

10.73

11.71

umol/l

2.12

331

2100

Other degenerative diseases of the nervous system

370

1.91

7.65

1.4

13.20

12.98

umol/l

0.08

348

Asthma (diagnoses ohter than nonallergic)

391

2467

1.36

7.64

1.3

1.4

12.21

12.00

umol/l

0.24

374

2333

Other acute lower respiratory infections

237

1532

1.48

7.64

1.4

12.93

12.17

umol/l

1.07

229

1451

Any event in cancer register

435

1919

1.35

7.61

1.3

1.4

11.76

12.00

umol/l

0.29

420

1820

Other obstetric conditions, not elsewhere classified

167

674

1.62

7.48

1.4

1.3

9.52

umol/l

0.00

158

650

Persons with potential health hazards related to communicable diseases

195

1270

1.53

7.37

1.3

1.4

10.92

11.08

umol/l

0.16

184

1220

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

163

657

1.62

7.33

1.4

1.3

9.52

9.51

umol/l

0.00

155

633

Obesity, other/unspecified

159

999

1.60

7.32

1.3

1.4

12.55

11.42

umol/l

1.23

145

955

Bacterial pneumonia, not elsewhere classified

152

835

1.62

7.22

1.2

1.4

14.68

12.67

umol/l

2.42

145

793

Infections of the skin and subcutaneous tissue

268

1875

1.43

7.20

1.4

13.32

11.94

umol/l

2.33

253

1779

Acute bronchitis

170

1069

1.56

7.13

1.4

13.51

12.24

umol/l

1.69

164

1012

Memory loss

169

2.50

7.08

1.3

1.5

13.88

14.44

umol/l

0.18

158

Injury, poisoning and certain other consequences of external causes

291

1024

1.43

7.00

1.4

12.47

11.41

umol/l

1.71

272

979

Congenital malformations of cardiac chambers and connections

14.36

6.96

1.6

1.3

13.00

9.00

umol/l

—

Benign neoplasm: Colon, unspecified

542

1.80

6.94

1.4

13.95

13.60

umol/l

0.17

506

Concussion

198

1140

1.51

6.92

1.4

11.34

11.74

umol/l

0.44

191

1087

Diabetes, varying definitions

474

2176

1.30

6.70

1.4

13.55

11.55

umol/l

7.14

436

2086

Type 2 diabetes

443

2003

1.32

6.67

1.4

13.57

11.71

umol/l

5.82

407

1923

Insulin, intermediate and long-acting

224

1516

1.45

6.66

1.4

14.12

12.69

umol/l

2.04

206

1439

Fracture of rib(s), sternum and thoracic spine

120

721

1.67

6.65

1.3

1.4

14.28

13.24

umol/l

0.77

111

682

Diabetes mellitus

476

2187

1.30

6.63

1.4

13.49

11.53

umol/l

6.91

438

2097

Bacterial pneumoniae

158

897

1.56

6.59

1.2

1.4

14.55

12.66

umol/l

2.28

150

852

Polyarthropathies

321

1560

1.37

6.59

1.3

1.4

13.68

12.02

umol/l

3.52

295

1489

Nontraumatic intracranial haemmorrhage

367

1.94

6.49

1.3

1.5

13.33

14.13

umol/l

0.38

344

Asthma-related pneumonia

141

887

1.59

6.47

1.3

1.4

14.00

12.66

umol/l

1.23

136

836

Thrombotic microangiopathy

14.90

6.46

1.8

1.4

14.80

8.14

umol/l

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

3.54

6.45

1.2

1.7

13.59

14.43

umol/l

0.17

Sleep disorders

106

622

1.71

6.44

1.4

11.25

11.64

umol/l

0.19

590

Asthma, hospital admissions 3, pneumonia

141

889

1.59

6.41

1.3

1.4

14.00

12.66

umol/l

1.23

136

838

Asthma-related pneumonia or sepsis

141

889

1.59

6.41

1.3

1.4

14.00

12.66

umol/l

1.23

136

838

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

114

2.74

6.28

1.7

1.5

11.47

14.86

umol/l

2.44

103

Volume depletion

161

2.44

6.26

1.3

1.5

16.04

14.47

umol/l

0.48

148

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

4.00

6.18

1.2

1.7

12.22

15.24

umol/l

0.87

Use of hypnotics and sedatives

483

2175

1.29

6.17

1.4

12.22

12.25

umol/l

0.04

452

2073

Acute upper respiratory infections

468

2283

1.29

6.07

1.4

11.97

12.06

umol/l

0.11

447

2155

Dementia, including avohilmo

134

577

1.61

6.04

1.7

1.4

15.46

14.70

umol/l

0.41

126

533

Mixed connective tissue disease

165

2.39

5.97

1.1

1.5

12.97

11.81

umol/l

0.55

154

Invasive ventilation

165

2.38

5.97

1.4

1.5

14.99

12.87

umol/l

0.73

156

Genitourinary diseases

310

1137

1.37

5.97

1.4

13.33

11.78

umol/l

2.88

293

1076

Agranulocytosis

275

2.05

5.96

1.4

1.5

12.61

12.41

umol/l

0.07

258

Convulsions, not elsewhere classified

100

584

1.70

5.92

1.2

1.5

12.97

11.93

umol/l

0.85

556

Fungal Sepsis

3.14

5.90

1.4

1.5

14.95

13.32

umol/l

0.37

Acute sinusitis

246

1647

1.40

5.88

1.3

1.4

11.53

umol/l

0.00

234

1567

Disorders of eyelid, lacrimal system and orbit

350

2075

1.33

5.88

1.4

12.16

12.34

umol/l

0.19

331

1967

Hypokalaemia

243

2.11

5.88

1.2

1.5

14.63

12.81

umol/l

0.68

224

Other viral diseases

145

940

1.54

5.86

1.3

1.4

11.55

11.47

umol/l

0.05

139

899

Cervicalgia

520

1.74

5.82

1.3

1.5

11.80

12.01

umol/l

0.13

487

Autoimmune hyperthyroidism

125

2.58

5.79

1.3

1.4

11.24

11.49

umol/l

0.06

118

Panic disorder

419

1.82

5.76

1.3

1.5

11.48

11.16

umol/l

0.16

402

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

244

1729

1.39

5.76

1.4

10.36

11.48

umol/l

1.80

230

1642

Persons encountering health services in other circumstances

157

1042

1.51

5.75

1.3

1.4

12.63

11.60

umol/l

1.07

149

993

Injuries to the hip and thigh

173

1070

1.48

5.74

1.4

15.81

12.84

umol/l

3.04

165

1009

Myocardial infarction, with ST-elevation

349

1.90

5.70

1.3

1.4

17.22

14.65

umol/l

1.25

327

Other specific joint derangements/joint disorders

355

1806

1.32

5.69

1.4

11.70

11.69

umol/l

0.01

334

1721

Streptococcal septicaemia

175

2.30

5.69

1.3

1.4

14.79

13.07

umol/l

0.63

161

Acute upper respiratory infections of multiple and unspecified sites

342

1941

1.32

5.65

1.3

1.4

12.18

11.70

umol/l

0.71

331

1840

Congenital malformations of pulmonary and tricuspid valves

13.23

5.62

1.1

1.9

12.22

11.73

umol/l

—

Finngen Rheumatological endpoints

459

2052

1.28

5.59

1.4

12.35

11.79

umol/l

1.02

436

1955

Mental disorders, not otherwise specified

242

2.08

5.56

1.5

12.10

11.16

umol/l

0.46

232

Disorders of ocular muscles, binocular movement, accommodation and refraction

209

1465

1.42

5.55

1.3

1.4

10.69

11.55

umol/l

1.34

192

1400

Secondary thrombocytopenia

5.35

5.55

1.5

1.9

12.27

12.82

umol/l

0.12

Aortic aneurysm

460

1.76

5.53

1.4

13.73

14.64

umol/l

0.47

426

Glucagon-like peptide-1 (GLP-1) analogues

198

1136

1.44

5.52

1.3

1.4

15.02

13.09

umol/l

3.01

181

1090

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

155

802

1.51

5.52

1.4

1.5

13.18

13.65

umol/l

0.30

146

754

Injuries to the thorax

176

1207

1.46

5.51

1.4

13.33

12.93

umol/l

0.31

165

1143

Type 2 diabetes, definitions combined

405

1873

1.29

5.46

1.4

14.17

11.81

umol/l

7.68

372

1801

Explicit bacterial Sepsis

217

2.13

5.46

1.4

1.5

13.89

13.08

umol/l

0.27

202

Allergic conjunctivitis

253

1823

1.37

5.46

1.4

10.42

11.46

umol/l

1.66

239

1733

Sequelae of external causes of morbidity and mortality

101

614

1.65

5.44

1.5

13.53

12.72

umol/l

0.40

576

Gingivitis and periodontal diseases

406

1621

1.29

5.42

1.4

12.54

11.81

umol/l

1.32

374

1541

Asthma, hospital admissions , main diagnosis only

361

2492

1.30

5.40

1.3

1.4

12.07

11.93

umol/l

0.15

347

2357

Symptoms and signs involving the urinary system

302

1751

1.34

5.39

1.4

13.46

12.56

umol/l

1.39

285

1660

Insulin, combination of fast acting with intermediate-acting or long-acting

245

1648

1.37

5.36

1.4

14.18

12.62

umol/l

2.54

226

1565

Social phobias

239

2.06

5.35

1.5

10.84

11.12

umol/l

0.15

232

Zoster [herpes zoster]

380

1.82

5.28

1.3

1.5

14.89

12.75

umol/l

1.28

359

Type 2 diabetes, strict (exclude DM1)

405

1884

1.29

5.26

1.4

14.17

11.83

umol/l

7.65

372

1811

Other disorders of kidney and ureter

296

1.94

5.24

1.4

1.5

16.92

13.34

umol/l

1.61

278

Soft tissue disorders related to use, overuse and pressure

107

667

1.61

5.23

1.4

1.5

13.40

12.60

umol/l

0.54

101

628

Gastro-oesophageal reflux disease

273

1801

1.34

5.22

1.3

1.4

12.61

12.18

umol/l

0.47

258

1715

Sulfasalazine

116

738

1.58

5.21

1.4

11.34

11.92

umol/l

0.64

111

698

Inflammatory diseases of female pelvic organs

253

1400

1.36

5.19

1.4

1.3

10.38

10.92

umol/l

0.69

244

1335

Obesity and other hyperalimentation

267

1969

1.34

5.17

1.3

1.4

13.08

11.52

umol/l

2.83

245

1880

Non-selective monoamine reuptake inhibitors

147

956

1.49

5.17

1.4

12.83

12.80

umol/l

0.02

137

912

Dermatitis

247

1819

1.36

5.17

1.3

1.4

12.23

12.22

umol/l

0.01

232

1729

Insulin medication

245

1538

1.36

5.13

1.4

14.18

12.26

umol/l

3.58

226

1478

Biological medication for rheuma

465

1.73

5.13

1.5

11.74

11.51

umol/l

0.12

445

Asthma, including avohilmo

532

2495

1.24

5.12

1.3

1.4

12.44

11.94

umol/l

0.78

507

2365

Disorders of choroid and retina

306

1686

1.32

5.12

1.4

13.35

12.86

umol/l

0.56

287

1596

Disorders of adult personality and behaviour

139

926

1.51

5.08

1.4

11.88

11.31

umol/l

0.39

122

893

Chronic lower respiratory diseases

556

2439

1.23

5.06

1.3

1.4

12.68

11.79

umol/l

1.94

526

2315

Implicit fungal Sepsis

2.99

5.00

1.5

14.70

13.56

umol/l

0.22

Migraine, single triptan purchase ok & required. ICD-code if available is included

368

1938

1.29

4.98

1.4

10.13

11.62

umol/l

6.68

349

1850

Triptan medication for migraine, single purchase ok

368

1938

1.29

4.98

1.4

10.13

11.62

umol/l

6.68

349

1850

Obesity

264

1960

1.34

4.94

1.3

1.4

13.13

11.52

umol/l

2.97

243

1871

Dementia

123

548

1.55

4.92

1.7

1.4

14.73

14.84

umol/l

0.05

115

505

Bacterial pneumonia (organism specified)

164

1035

1.45

4.86

1.2

1.4

14.37

12.87

umol/l

1.64

155

974

Nonorganic sleeping disorders

564

1.64

4.85

1.4

1.5

10.83

11.59

umol/l

0.38

534

Other and unspecified disorders of binocular movement

11.82

4.82

1.0

1.3

11.61

10.86

umol/l

—

Any dementia

106

470

1.59

4.75

1.7

1.4

15.24

14.87

umol/l

0.15

101

433

Diseases of the respiratory system

311

1187

1.31

4.69

1.4

12.57

11.57

umol/l

1.59

294

1124

Secondary hypertension

132

2.34

4.63

1.4

1.5

17.63

11.77

umol/l

2.12

126

Other and unspecified dermatitis

205

1496

1.37

4.61

1.3

1.4

12.02

12.12

umol/l

0.08

192

1422

Infections with a predominantly sexual mode of transmission

145

996

1.46

4.58

1.4

11.46

10.71

umol/l

0.64

136

952

Thyrotoxicosis with diffuse goitre

340

1.80

4.55

1.3

1.4

11.27

11.85

umol/l

0.28

329

Benign neoplasm: Rectum, anus and anal canal

399

1.74

4.54

1.5

13.48

13.81

umol/l

0.12

376

Other disorders of lacrimal gland

132

893

1.48

4.53

1.5

1.4

11.43

12.14

umol/l

0.65

126

843

Cholecystitis

283

1.88

4.53

1.7

1.4

13.58

13.63

umol/l

0.02

262

Angina pectoris

207

1016

1.38

4.51

1.5

1.4

14.97

13.26

umol/l

2.35

191

960

Personality disorders

130

878

1.49

4.50

1.3

1.4

12.04

11.27

umol/l

0.52

114

844

Fissure and fistula of anal and rectal regions

607

1.59

4.49

1.4

12.52

12.51

umol/l

0.01

577

Type 2 diabetes, definitions combined, including avohilmo

401

1890

1.26

4.44

1.4

13.96

11.79

umol/l

6.89

370

1820

Cellulitis

610

1.58

4.41

1.4

1.5

13.67

12.55

umol/l

0.76

579

Myocardial infarction, without ST-elevation

126

782

1.49

4.40

1.4

16.32

14.35

umol/l

1.62

115

731

Complex cardiac defects

7.77

4.40

1.2

1.5

13.67

10.33

umol/l

—

Neuromuscular dysfunction of bladder

224

1.98

4.35

1.5

12.19

12.88

umol/l

0.27

210

Gastroduodenal ulcer

556

1.60

4.34

1.3

1.4

13.86

13.75

umol/l

0.04

521

Other diseases of pleura

151

935

1.43

4.32

1.5

1.4

14.71

13.82

umol/l

0.61

142

875

Disorders of lacrimal system

157

1110

1.42

4.29

1.5

1.4

11.13

12.15

umol/l

1.32

149

1053

Hernia

401

2182

1.25

4.28

1.4

13.35

12.14

umol/l

2.70

378

2072

Fracture of lumbar spine and pelvis

469

1.64

4.19

1.4

1.5

13.88

12.96

umol/l

0.59

439

Lymphangioma, anys site

7.11

4.19

1.0

1.5

8.86

9.80

umol/l

—

Lymphangioma, anys site

7.11

4.19

1.0

1.5

8.86

9.49

umol/l

—

Insomnia

470

1.65

4.19

1.5

1.4

10.14

11.68

umol/l

1.91

447

Chronic sinusitis

180

1308

1.38

4.19

1.2

1.4

11.64

12.04

umol/l

0.29

169

1242

Superficial injury of head

573

1.58

4.12

1.5

13.55

12.29

umol/l

0.76

549

Diseases of salivary glands

473

1.63

4.09

1.2

1.4

12.71

12.09

umol/l

0.32

451

Disorders of lens

257

1236

1.31

4.09

1.4

13.83

12.86

umol/l

1.19

239

1175

Systemic disorders of connective tissue in diseases classified elsewhere

10.43

4.05

1.4

1.1

15.86

14.29

umol/l

—

Defects in the complement system

10.24

4.03

1.7

1.6

11.10

9.57

umol/l

—

Right ventricular outflow tract obstruction

6.59

4.01

1.1

1.6

12.78

10.72

umol/l

—

Fracture of skull and facial bones

570

1.57

3.99

1.4

1.5

12.39

12.32

umol/l

0.04

546

Cramp and spasm

124

2.28

3.97

1.6

1.5

12.36

12.68

umol/l

0.10

117

Cutaneous abscess, furuncle and carbuncle

110

739

1.49

3.96

1.5

1.4

12.41

12.11

umol/l

0.19

103

706

Ascites

144

2.17

3.92

1.6

1.4

15.72

13.45

umol/l

0.78

134

Polyuria

518

1.59

3.91

1.4

13.02

13.26

umol/l

0.12

486

Disorders of vitreous body and globe

173

1234

1.37

3.89

1.4

12.23

13.16

umol/l

0.89

164

1164

Malignant neoplasm of digestive organs

119

802

1.46

3.89

1.4

13.87

14.24

umol/l

0.18

112

749

Disorders of sclera, cornea, iris and ciliary body

220

1670

1.32

3.89

1.4

12.22

12.12

umol/l

0.08

208

1586

Disorders of vitreous body

169

1206

1.37

3.88

1.4

12.24

13.16

umol/l

0.87

162

1138

Sequelae with surgical and medical care as external cause

458

1.62

3.84

1.5

14.19

12.96

umol/l

0.49

430

Livedoid vasculitis

12.51

3.80

1.3

1.2

15.17

13.00

umol/l

—

Other hereditary haemolytic anaemias

8.99

3.80

2.6

1.8

11.86

9.50

umol/l

—

Dorsalgia

451

2005

1.22

3.79

1.4

12.26

11.95

umol/l

0.42

428

1899

Osteoporosis with pathological fracture (FG)

115

2.27

3.71

1.3

1.6

13.23

12.51

umol/l

0.17

106

Other and unspecified disorders of vitreous body

140

993

1.41

3.70

1.4

11.78

13.13

umol/l

1.52

135

940

Low back pain

314

1926

1.26

3.70

1.4

13.26

11.95

umol/l

2.32

298

1829

Irregular menses

199

1213

1.33

3.69

1.3

10.50

10.30

umol/l

0.19

189

1161

Haemorrhoids and perianal venous thrombosis

629

1.51

3.68

1.4

12.74

12.91

umol/l

0.08

588

Other symptoms and signs involving the nervous and musculoskeletal systems

163

1196

1.37

3.64

1.3

1.4

12.39

11.83

umol/l

0.45

149

1137

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

3.48

3.63

1.3

1.6

10.24

9.56

umol/l

0.19

Injuries to the abdomen, lower back, lumbar spine and pelvis

144

1029

1.39

3.62

1.4

13.36

12.35

umol/l

0.84

134

976

Conjunctivitis (acute, non atopic)

115

793

1.45

3.61

1.3

1.4

11.31

11.88

umol/l

0.54

110

755

Unspecified haematuria

142

873

1.40

3.56

1.4

14.73

13.37

umol/l

1.38

133

823

Abnormal findings on diagnostic imaging of lung

156

1111

1.37

3.55

1.4

14.91

13.50

umol/l

1.29

147

1043

Vitamin deficiency

111

2.27

3.55

1.4

1.5

14.65

12.50

umol/l

0.57

103

Vitamin deficiency, wide

111

2.27

3.55

1.4

1.5

14.65

12.50

umol/l

0.57

103

Drug-induced systemic lupus erythematosus

6.32

3.53

1.5

1.8

13.56

12.45

umol/l

—

Allergic colitis

2.91

3.46

1.7

1.8

10.19

9.84

umol/l

0.10

Dental caries 2 and operation codes

337

2169

1.24

3.46

1.4

11.12

11.54

umol/l

0.59

317

2061

Noninflammatory disorders of female genital tract

187

700

1.35

3.45

1.5

1.3

10.57

10.94

umol/l

0.30

175

666

Schizophrenia or delusion, excluding more controls

122

855

1.42

3.44

1.2

1.4

12.19

11.97

umol/l

0.12

832

Epilepsy

115

803

1.43

3.40

1.3

1.4

12.34

12.38

umol/l

0.02

105

768

Open wound of head

197

1481

1.31

3.40

1.4

14.46

12.54

umol/l

2.19

185

1405

Infarction of spleen

7.22

3.39

1.3

2.2

12.26

13.01

umol/l

—

Other specified/unspecified systemic involvement of connective tissue

147

2.05

3.36

1.1

1.5

12.88

11.72

umol/l

0.45

138

Scoliosis

225

1.83

3.32

1.4

1.5

11.94

11.61

umol/l

0.10

210

Other dorsopathies, not elsewhere classified

460

2025

1.20

3.31

1.3

1.4

12.27

11.93

umol/l

0.49

436

1917

Multiple myeloma and malignant plasma cell neoplasms

2.48

3.30

1.3

1.6

16.78

15.05

umol/l

0.31

Menorrhagia

143

570

1.39

3.29

1.5

1.4

10.55

11.17

umol/l

0.51

136

540

Insulin, fast-acting

140

1021

1.37

3.28

1.4

13.19

12.32

umol/l

0.71

131

970

Dental caries 2

341

2188

1.23

3.27

1.3

1.4

11.18

11.53

umol/l

0.47

319

2081

Rheumatoid arthritis

123

798

1.40

3.25

1.3

1.4

12.23

12.29

umol/l

0.03

115

760

Specific personality disorders

109

764

1.43

3.24

1.3

1.4

12.07

11.30

umol/l

0.43

735

Diseases of inner ear

188

1408

1.31

3.21

1.4

12.76

12.70

umol/l

0.04

175

1337

Allergic asthma (mode), excluding more controls

103

703

1.44

3.19

1.4

10.25

10.53

umol/l

0.19

662

Intestinal adhesions without obstruction

164

1.96

3.19

1.3

1.4

14.13

12.32

umol/l

1.04

152

Substance abuse, excluding more controls

212

1442

1.29

3.17

1.3

1.4

13.78

12.39

umol/l

1.57

177

1388

Post-traumatic stress disorder

207

1.84

3.16

1.2

1.5

9.89

10.40

umol/l

0.28

196

Other and unspecified effects of external causes

115

818

1.41

3.16

1.3

1.4

11.21

11.64

umol/l

0.37

106

782

Other forms of systemic lupus erythematosus

4.60

3.13

1.2

1.7

12.86

11.68

umol/l

—

Intracranial injury

217

1640

1.28

3.13

1.4

11.75

12.06

umol/l

0.36

206

1560

Lung transplant status

5.13

3.07

1.4

1.7

12.13

11.12

umol/l

—

Lung transplantation

5.13

3.07

1.4

1.8

12.13

11.12

umol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

2.39

3.06

1.7

1.6

11.33

15.10

umol/l

2.07

Other disorders of eyelid

141

1007

1.35

3.06

1.4

13.41

13.21

umol/l

0.12

133

948

Disorders of vestibular function (Vertigo)

160

1198

1.33

3.06

1.4

12.87

12.60

umol/l

0.16

148

1136

Other and unspecified injuries of head

139

2.03

3.06

1.3

1.5

14.35

12.99

umol/l

0.41

134

Rheumatoid arthritis, including avohilmo

137

1010

1.36

3.04

1.3

1.4

12.10

12.47

umol/l

0.25

128

959

Disorders of skin appendages

196

1520

1.29

3.04

1.4

11.80

11.59

umol/l

0.19

183

1444

Osteopathy in diseases classified elsewhere

5.97

3.04

1.1

1.2

12.14

12.25

umol/l

—

Temporomandibular joint disorders, including avohilmo

175

1336

1.31

3.04

1.3

1.4

10.08

11.08

umol/l

2.07

166

1278

In situ neoplasms

116

794

1.40

3.02

1.5

1.4

13.68

12.46

umol/l

0.86

110

742

Polyp of the female genital tract

124

517

1.40

3.02

1.4

10.73

11.27

umol/l

0.42

119

489

Benign neoplasm: Rectum, anus and anal canal

448

1.54

3.01

1.5

13.48

13.82

umol/l

0.12

421

Eclampsia

10.46

3.01

1.0

1.8

11.38

10.40

umol/l

—

Thyrotoxicosis factitia

10.39

3.01

2.0

1.2

6.28

10.20

umol/l

—

Anosmia

3.43

2.99

1.4

12.33

10.37

umol/l

—

Injuries to the elbow and forearm

277

2027

1.24

2.97

1.4

12.40

12.02

umol/l

0.36

266

1913

Other and unspecified myopathies

183

1.87

2.96

1.1

1.5

15.55

14.16

umol/l

0.36

171

Exclusions for E4_PCOS_CONSORTIUM

304

1554

1.23

2.91

1.4

10.86

11.26

umol/l

0.44

285

1489

COPD (mode)

524

1.44

2.90

1.3

1.5

17.01

13.07

umol/l

2.98

493

Social disorders starting during childhood or adolecense, excluding more controls

5.48

2.88

1.6

1.9

11.14

9.81

umol/l

—

Other diseases of gallbladder

2.26

2.87

1.5

13.79

13.59

umol/l

0.05

Atrophic disorders of skin

351

1.60

2.86

1.4

1.5

9.69

11.69

umol/l

2.40

333

Triptan medication for migraine, min. 3 purchases

239

1507

1.25

2.86

1.3

1.4

9.60

10.93

umol/l

4.11

227

1446

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

159

785

1.33

2.85

1.3

1.4

11.24

11.30

umol/l

0.04

154

745

Acute tubulo-interstitial nephritis

218

1532

1.26

2.84

1.4

13.93

11.68

umol/l

4.12

207

1446

Insulin, fast-acting or short human

141

1056

1.34

2.84

1.4

13.19

12.47

umol/l

0.56

132

1002

Colonic or urogenital fistula

103

734

1.41

2.84

1.4

12.67

12.63

umol/l

0.02

697

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

159

786

1.32

2.82

1.3

1.4

11.24

11.30

umol/l

0.03

154

746

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

2.79

2.82

1.5

1.6

12.53

14.80

umol/l

0.58

Complications of other internal prosthetic devices, implants and grafts

2.48

2.79

1.6

1.5

12.26

12.69

umol/l

0.09

Adverse effects, not elsewhere classified

546

1.47

2.79

1.3

1.4

11.20

11.57

umol/l

0.23

521

Striae atrophicae

3.98

2.79

1.2

1.4

8.47

9.53

umol/l

—

Multiple myeloma and malignant plasma cell neoplasms

2.28

2.77

1.3

1.5

16.78

13.53

umol/l

0.73

Multiple myeloma, excluding all cancers (controls excluding all cancers)

2.28

2.77

1.3

1.5

16.78

13.53

umol/l

0.73

Other congenital malformations of kidney

8.57

2.77

1.6

1.0

8.86

11.00

umol/l

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.28

2.76

1.2

1.7

11.10

10.48

umol/l

0.16

Other diseases of upper respiratory tract

476

2117

1.17

2.74

1.3

1.4

12.01

12.34

umol/l

0.44

452

2002

Allergic asthma (mode)

103

727

1.39

2.71

1.4

10.25

10.86

umol/l

0.50

686

Coronary angioplasty

114

638

1.37

2.67

1.5

1.4

16.39

13.82

umol/l

2.58

106

593

Other specified/unspecified bacterial intestinal infections

154

1.89

2.66

1.8

1.5

13.12

12.78

umol/l

0.09

145

Autoimmune thyroiditis

3.16

2.65

1.7

10.26

10.84

umol/l

—

Early onset COPD, excluding more controls

454

1.50

2.65

1.4

15.47

12.67

umol/l

1.52

427

Pain and other conditions associated with female genital organs and menstrual cycle

537

1.45

2.65

1.3

10.21

10.27

umol/l

0.03

509

Diabetes medication

435

2251

1.18

2.64

1.4

13.61

11.72

umol/l

5.50

397

2156

Female infertility

125

571

1.35

2.59

1.5

1.3

10.14

10.78

umol/l

0.61

119

543

Excessive attrition of teeth

151

622

1.32

2.58

1.3

10.93

11.15

umol/l

0.19

141

597

Paralytic ileus

2.37

2.56

1.7

1.5

12.18

12.96

umol/l

0.22

In situ neoplasms

116

860

1.35

2.55

1.5

1.4

13.68

12.53

umol/l

0.79

110

807

Benign neoplasm: Sigmoid colon

370

1.54

2.55

1.3

1.5

14.23

13.73

umol/l

0.17

347

Glomerular disorders in diseases classified elsewhere

284

1.63

2.54

1.4

1.5

20.22

13.23

umol/l

3.35

264

Degenerative macular diseases

223

1.71

2.53

1.3

1.5

13.83

13.91

umol/l

0.02

208

Ovarian cyst

146

642

1.32

2.51

1.4

1.3

10.84

11.06

umol/l

0.16

134

608

Type 1 diabetes

101

734

1.38

2.51

1.4

12.58

11.53

umol/l

0.73

707

Cyst of kidney

129

1.95

2.50

1.4

15.98

14.24

umol/l

0.37

121

Senile cataract

215

1067

1.25

2.50

1.4

14.26

13.09

umol/l

1.38

197

1012

Disorders of refraction and accommodation

108

792

1.36

2.50

1.2

1.4

10.93

11.45

umol/l

0.41

758

Other noninfective disorders of lymphatic vessels and lymph nodes

2.21

2.48

1.6

1.5

9.81

12.43

umol/l

1.35

Migraine without aura, drug-induced

3.86

2.47

1.1

1.7

9.03

10.80

umol/l

—

Other and unspecified nonorganic psychotic disorders

594

1.42

2.47

1.2

1.5

11.73

11.52

umol/l

0.09

572

Unstable angina pectoris

112

686

1.36

2.47

1.5

1.4

14.36

14.01

umol/l

0.21

101

640

Spondylopathies

309

1563

1.20

2.45

1.4

13.26

12.47

umol/l

1.12

294

1485

Spondylosis

191

1304

1.26

2.45

1.4

13.53

12.76

umol/l

0.78

181

1233

Injuries to the ankle and foot

291

2208

1.20

2.44

1.3

1.4

12.08

11.46

umol/l

0.87

275

2102

Fibrosis of liver

5.10

2.42

1.3

1.7

9.17

11.42

umol/l

—

Keratitis

130

991

1.31

2.39

1.4

12.58

12.09

umol/l

0.38

123

948

Atrioventricular septal defect

6.42

2.39

1.0

1.4

9.80

9.75

umol/l

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.41

2.39

1.0

1.8

8.80

8.50

umol/l

—

Parodontitis

349

2180

1.18

2.36

1.3

1.4

14.07

12.11

umol/l

5.37

323

2078

Pregnancy examination and test

308

1.46

2.34

1.3

9.48

9.80

umol/l

0.23

294

Urticaria and erythema

145

1126

1.29

2.34

1.4

11.18

11.48

umol/l

0.20

137

1072

Parodontitis or operation codes

349

2181

1.18

2.33

1.3

1.4

14.07

12.11

umol/l

5.38

323

2079

Injuries to the knee and lower leg

501

2495

1.15

2.32

1.3

1.4

11.91

12.08

umol/l

0.24

466

2373

Other specified disorders of kidney and ureter

2.20

2.31

1.4

1.6

12.87

13.45

umol/l

0.12

Dystonia

133

1.89

2.31

1.4

11.27

12.01

umol/l

0.22

126

Malignant neoplasm of breast, HER2-negative

163

941

1.27

2.31

1.3

1.4

11.63

11.58

umol/l

0.03

158

892

Lymphoid leukaemia

105

2.01

2.31

1.5

1.6

12.21

14.59

umol/l

0.99

Other cataract

141

843

1.30

2.30

1.3

1.4

14.63

12.99

umol/l

1.44

128

796

Thyroiditis

177

1.76

2.30

1.6

1.5

10.67

11.40

umol/l

0.27

166

Malignant neoplasm of breast

168

956

1.27

2.30

1.3

1.4

11.58

11.52

umol/l

0.03

163

906

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

387

2021

1.17

2.29

1.4

13.99

11.72

umol/l

6.95

353

1939

Other sleep disorders

261

1.61

2.29

1.2

1.5

12.18

12.93

umol/l

0.27

243

Seborrhoeic keratosis

470

1.45

2.29

1.5

1.4

12.86

12.92

umol/l

0.02

439

Selective deficiency of immunoglobulin G [IgG] subclasses

4.70

2.28

2.2

9.12

10.45

umol/l

—

Infliximab

4.69

2.28

1.7

1.5

12.00

9.15

umol/l

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.69

2.28

1.2

1.9

8.43

10.03

umol/l

—

Retention of urine

104

652

1.35

2.28

1.3

1.4

14.58

13.77

umol/l

0.49

608

Convergence insufficiency and excess

3.52

2.27

1.4

1.5

10.00

10.20

umol/l

—

Social disorders starting during childhood or adolescence

3.95

2.26

1.6

1.9

11.14

9.69

umol/l

—

Fracture of forearm

201

1525

1.24

2.26

1.4

12.17

12.11

umol/l

0.04

193

1439

Other retinal disorders

203

1320

1.24

2.26

1.3

1.4

13.50

13.10

umol/l

0.33

189

1244

Dental operations

276

1175

1.21

2.25

1.4

12.86

12.25

umol/l

0.73

261

1112

Unspecified mental disorder

165

1310

1.26

2.24

1.4

12.42

11.68

umol/l

0.63

125

1258

Parodontitis and operation codes

326

2149

1.18

2.22

1.3

1.4

13.84

12.18

umol/l

3.84

301

2048

Other and unspecified papulosquamous disorders

5.66

2.22

1.0

1.6

16.02

13.90

umol/l

—

Type 1 diabetes, wide definition, subgroup 1

598

1.39

2.22

1.4

12.52

11.34

umol/l

0.72

573

Nerve, nerve root and plexus disorders

425

2308

1.16

2.21

1.3

1.4

12.74

12.12

umol/l

0.97

399

2199

Lymphoid leukaemia

107

1.97

2.20

1.5

1.6

12.21

14.32

umol/l

0.83

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

4.37

2.16

1.2

1.9

11.17

12.56

umol/l

—

N06DA Anticholinesterases

437

1.41

2.16

1.8

1.4

14.65

15.12

umol/l

0.20

405

Use of anticholinesterases

437

1.41

2.16

1.8

1.4

14.65

15.12

umol/l

0.20

405

Other symptoms and signs involving the circulatory and respiratory systems

151

1.80

2.16

1.5

12.85

12.00

umol/l

0.21

143

Hypersomnia

3.03

2.15

1.0

1.5

13.90

13.04

umol/l

—

Non-Hodgkin lymphoma, all

2.18

2.15

1.1

1.6

16.61

15.52

umol/l

0.26

Chronic periodontitis, including avohilmo

345

2182

1.17

2.14

1.3

1.4

14.12

12.12

umol/l

5.47

319

2080

Gastric ulcer

370

1.49

2.14

1.3

1.5

13.91

13.77

umol/l

0.04

346

Paracetamol of NSAID medication

341

1.38

2.12

1.5

1.4

12.18

12.32

umol/l

0.06

320

Excessive, frequent and irregular menstruation

156

683

1.27

2.11

1.5

1.3

10.20

10.97

umol/l

0.91

148

649

Polycystic ovarian syndrome, consortium definition

276

1395

1.19

2.11

1.4

1.3

10.83

umol/l

0.00

263

1334

Drug-induced neutropenia

175

1.72

2.09

1.5

13.27

12.29

umol/l

0.30

166

Obesity due to excess calories

178

1440

1.24

2.08

1.3

1.4

13.67

11.49

umol/l

3.37

165

1369

Cardiomyopathies, Secondary/extrinsic

5.09

2.08

1.8

1.4

15.58

13.40

umol/l

—

Lower back pain or/and sciatica

415

2501

1.15

2.07

1.4

12.78

11.99

umol/l

1.38

394

2375

Demyelinating diseases of the central nervous system

245

1.60

2.06

1.3

1.5

12.63

11.31

umol/l

0.56

229

Unspecific neurodegenerative disorder

509

1.34

2.06

1.7

1.4

14.38

15.00

umol/l

0.28

473

Malignant neoplasm of bone and articular cartilage

4.06

2.05

1.2

1.5

13.33

11.40

umol/l

—

Unequal limb length (acquired)

4.05

2.04

1.3

1.9

12.17

10.69

umol/l

—

Diseases of external ear

119

922

1.29

2.01

1.3

1.4

12.05

12.46

umol/l

0.31

108

877

Scar conditions and fibrosis of skin

1.97

2.00

1.4

1.5

8.76

11.17

umol/l

1.37

Benign paroxysmal vertigo

680

1.34

1.99

1.4

12.69

12.68

umol/l

0.01

643

Coronary revascularization (ANGIO or CABG)

138

757

1.27

1.98

1.5

1.4

16.50

13.75

umol/l

3.21

129

710

Arthropathies

422

1870

1.15

1.97

1.4

12.03

11.74

umol/l

0.37

399

1779

Right side

4.64

1.95

1.4

2.4

12.79

14.28

umol/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.61

1.95

1.8

1.6

10.32

10.73

umol/l

—

Rheumatism, unspecified

313

1.51

1.94

1.3

1.4

11.38

11.68

umol/l

0.11

298

Hernia of abdominal wall

155

1246

1.25

1.94

1.2

1.4

13.75

12.78

umol/l

0.87

149

1178

Seropositive rheumatoid arthritis

638

1.35

1.94

1.3

1.4

11.88

12.31

umol/l

0.26

599

Striking against or struck by other objects

130

1024

1.27

1.93

1.3

1.4

11.33

12.08

umol/l

0.89

120

972

Disorders of breast

176

1330

1.23

1.92

1.4

1.3

9.64

11.14

umol/l

3.55

168

1269

Urolithiasis

108

832

1.30

1.92

1.4

14.66

13.37

umol/l

0.83

783

Dorsopathies

456

2042

1.14

1.91

1.4

12.12

11.91

umol/l

0.28

440

1933

Left ventricular outflow tract obstruction, narrow definition

135

1.79

1.91

1.4

1.6

12.25

12.64

umol/l

0.10

129

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

372

1.45

1.90

1.4

1.5

14.97

14.01

umol/l

0.25

347

Calculus of kidney and ureter

102

781

1.31

1.90

1.4

14.70

13.16

umol/l

0.98

733

Abnormal spermatozoa

240

0.46

1.90

1.5

1.4

13.93

15.46

umol/l

0.47

224

Dental caries 1 and operation codes

363

1609

1.16

1.89

1.4

12.67

12.08

umol/l

0.86

339

1530

Lifestyle-related condition

3.22

1.88

1.3

1.7

18.81

11.50

umol/l

—

Other factor of the environment

3.22

1.88

1.3

1.7

18.81

11.59

umol/l

—

Other (not insulin) diabetes medications

376

1970

1.15

1.87

1.3

1.4

14.07

11.96

umol/l

5.80

341

1891

Disorders resulting from impaired renal tubular function

2.10

1.86

1.5

1.6

23.40

13.56

umol/l

1.56

Dipeptidyl peptidase 4 (DPP-4) inhibitors

252

1.55

1.86

1.3

1.5

16.25

13.69

umol/l

0.80

243

Diseases of the ear and mastoid process

516

2316

1.13

1.84

1.4

11.72

12.05

umol/l

0.54

485

2202

Benign neoplasm: Sigmoid colon

400

1.43

1.83

1.3

1.5

14.23

13.80

umol/l

0.14

376

Prophylactic surgery

4.22

1.83

1.0

1.9

8.24

9.31

umol/l

—

Diabetes, insulin treatment (Kela reimbursement)

405

2169

1.14

1.82

1.4

14.05

11.93

umol/l

6.44

370

2079

COPD

132

866

1.26

1.79

1.4

1.5

16.72

13.45

umol/l

3.27

120

809

Later onset COPD, excluding more controls

280

1.45

1.76

1.2

1.5

19.37

14.30

umol/l

2.65

257

Varicella [chickenpox]

124

1.78

1.76

1.3

1.5

11.89

12.18

umol/l

0.09

116

Panniculitis affecting regions of neck and back

1.94

1.75

1.5

14.36

12.00

umol/l

0.48

Contact with and exposure to communicable diseases

133

1063

1.25

1.73

1.3

1.4

10.39

10.80

umol/l

0.44

125

1026

Atopic dermatitis

231

1668

1.18

1.72

1.4

10.84

11.17

umol/l

0.39

216

1591

Methotrexate

339

1.45

1.72

1.1

1.5

14.75

12.07

umol/l

1.55

321

Chronic lymphocytic leukaemia, helper endpoint

2.31

1.71

1.8

1.7

12.73

15.11

umol/l

0.56

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

2.31

1.71

1.8

1.7

12.73

15.11

umol/l

0.56

Degeneration of macula and posterior pole

123

806

1.26

1.70

1.3

1.4

14.02

14.11

umol/l

0.04

111

751

Presence of other functional implants

163

945

1.22

1.69

1.3

1.4

12.97

13.24

umol/l

0.18

156

882

Exposure to other specified factors

295

2396

1.16

1.67

1.3

1.4

11.96

11.84

umol/l

0.11

278

2272

Unspecified fall

168

1377

1.21

1.67

1.3

1.4

13.26

12.31

umol/l

0.76

156

1308

Seropositive rheumatoid arthritis, wide

657

1.31

1.67

1.3

1.4

11.88

12.73

umol/l

0.61

620

Emergency coronary revascularization (for ACS)

156

916

1.22

1.66

1.4

16.43

14.16

umol/l

2.70

146

856

Tinnitus

616

1.32

1.63

1.6

1.5

12.68

12.57

umol/l

0.04

583

Benign leiomyoma with endometriosis

327

1.44

1.62

1.6

1.4

11.51

11.70

umol/l

0.07

311

Other disorders of bone

565

1.33

1.61

1.5

1.4

12.64

12.02

umol/l

0.28

537

Dental caries 3 and operation codes

377

1700

1.14

1.60

1.4

12.51

11.97

umol/l

0.81

352

1618

Malignant neoplasm of colon

295

1.46

1.59

1.4

14.92

14.16

umol/l

0.16

276

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

238

1.52

1.59

1.5

14.08

12.71

umol/l

0.50

219

Lactose intolerance

1.96

1.59

1.5

1.6

15.34

11.42

umol/l

0.57

Dental caries 3

344

1537

1.14

1.59

1.4

12.41

11.95

umol/l

0.61

324

1469

Atopic dermatitis, strict definition with reimbursement

127

995

1.24

1.58

1.4

10.82

10.96

umol/l

0.10

121

955

Other specified/unspecified arthritis

751

1.28

1.58

1.3

1.4

12.31

12.02

umol/l

0.22

720

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

175

1.61

1.57

1.3

1.5

10.75

11.43

umol/l

0.27

164

Abrasion of teeth

485

1.31

1.57

1.4

12.34

11.49

umol/l

0.66

466

Vulvovaginal ulceration/inflammation in other diseases

152

1.65

1.56

1.7

1.4

9.92

9.85

umol/l

0.01

140

Combinations of oral blood glucose lowering drugs

673

1.29

1.56

1.3

1.5

15.02

13.22

umol/l

1.32

646

Bipolar affective disorders

570

1.32

1.53

1.3

1.5

11.89

11.38

umol/l

0.32

549

Other specified and unspecified personality disorders

273

1.47

1.53

1.3

1.5

12.60

11.28

umol/l

0.28

259

Alcohol abuse, main dg, excluding more controls

390

1.39

1.53

1.1

1.5

14.58

13.00

umol/l

0.66

378

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

194

1606

1.18

1.53

1.4

11.97

12.26

umol/l

0.22

188

1525

Other/unspecified seropositive rheumatoid arthritis

641

1.30

1.51

1.3

1.5

11.88

12.68

umol/l

0.54

606

Oral lichen ruber planus, including avohilmo

143

0.42

1.51

1.5

8.30

12.02

umol/l

—

135

Schizophrenia or delusion

122

988

1.24

1.51

1.2

1.4

12.19

11.91

umol/l

0.15

952

Other obstructed labour

205

0.49

1.50

1.1

1.3

8.98

10.53

umol/l

—

196

Shoulder lesions

287

1528

1.15

1.49

1.4

12.51

12.55

umol/l

0.04

271

1450

Dental caries, including avohilmo

321

1436

1.14

1.48

1.4

12.49

12.03

umol/l

0.56

300

1371

Gonarthrosis, primary, with knee surgery

114

1152

0.81

1.48

1.4

13.59

13.64

umol/l

0.02

107

1086

Spinal stenosis

156

1015

1.21

1.47

1.4

14.51

13.32

umol/l

0.99

148

957

Other strabismus

651

1.29

1.47

1.3

1.5

10.70

11.54

umol/l

0.66

622

Fracture of shoulder and upper arm

118

955

1.24

1.47

1.2

1.4

13.66

12.53

umol/l

0.85

109

904

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

113

901

1.24

1.46

1.5

1.4

9.95

10.63

umol/l

0.84

105

865

Dental caries 1

321

1438

1.14

1.46

1.4

12.49

12.04

umol/l

0.54

300

1373

Other joint disorders

394

1865

1.13

1.45

1.4

11.47

11.76

umol/l

0.41

372

1774

Type 1 diabetes, wide definition

654

1.29

1.44

1.4

12.59

11.47

umol/l

0.68

628

Benign lipomatous neoplasm

718

1.27

1.42

1.4

1.5

11.98

12.62

umol/l

0.44

681

Strabismus

779

1.26

1.42

1.3

1.4

10.73

11.83

umol/l

1.11

743

Other chronic obstructive pulmonary disease

124

841

1.23

1.42

1.3

1.5

17.01

13.51

umol/l

3.36

113

785

Dialysis

1.83

1.41

1.6

16.73

12.72

umol/l

1.05

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

641

1.28

1.39

1.3

1.4

14.08

12.20

umol/l

1.51

621

Colorectal cancer, excluding all cancers (controls excluding all cancers)

560

1.30

1.39

1.4

1.5

14.92

13.86

umol/l

0.38

523

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

633

1.28

1.38

1.3

1.5

11.99

12.55

umol/l

0.33

599

Dental pulpitis 1

463

2165

1.11

1.38

1.3

1.4

12.76

11.83

umol/l

1.97

432

2061

Schizophrenia, schizotypal and delusional disorders

121

991

1.22

1.37

1.2

1.4

12.21

11.91

umol/l

0.16

955

Dental pulpitis 4

463

2165

1.11

1.37

1.3

1.4

12.76

11.83

umol/l

1.97

432

2061

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

100

803

1.25

1.36

1.2

1.4

11.01

11.52

umol/l

0.28

783

Diseases of pulp and periapical tissues, including avohilmo

461

2161

1.11

1.32

1.3

1.4

12.77

11.83

umol/l

2.03

432

2057

Graves disease, strict definition

266

1.43

1.32

1.4

1.5

10.37

10.97

umol/l

0.32

251

Congenital malformations of great arteries

2.12

1.31

1.2

1.9

12.76

10.34

umol/l

—

Chronic diseases of tonsils and adenoids

338

1902

1.13

1.31

1.3

1.4

10.80

11.98

umol/l

3.31

320

1807

Otitis externa

595

1.28

1.29

1.1

1.4

11.59

12.19

umol/l

0.37

566

Persons encountering health services in circumstances related to reproduction

243

1436

1.15

1.28

1.5

1.4

10.80

11.84

umol/l

2.34

235

1368

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

276

1.42

1.28

1.3

1.5

15.31

13.72

umol/l

0.74

255

Other and unspecified disorders of psychological development

2.48

1.28

1.0

1.8

8.33

8.90

umol/l

—

Malignant neoplasm of ovary

1.72

1.27

1.6

1.5

10.24

12.05

umol/l

0.79

MS-disease / Multiple Sclerosis

202

1.49

1.27

1.4

1.5

12.50

11.02

umol/l

0.51

187

Melanoma in situ

1.83

1.25

1.4

1.7

12.97

13.97

umol/l

0.18

Dental pulpitis 2

288

1300

1.14

1.25

1.4

12.64

12.04

umol/l

0.73

271

1242

Fracture of lower leg, including ankle

196

1686

1.16

1.25

1.2

1.4

12.00

12.23

umol/l

0.19

173

1606

Granuloma annulare

2.42

1.24

1.5

1.9

10.58

11.60

umol/l

—

Failed induction of labour

159

0.50

1.24

1.3

1.4

8.74

9.59

umol/l

—

150

Pervasive developmental disorders excl. Autism + Asperger

2.41

1.24

1.8

8.83

10.04

umol/l

—

COPD related to multimorbidity

106

729

1.23

1.24

1.3

1.4

17.92

14.11

umol/l

3.04

678

Pleural plaque

189

0.53

1.22

1.3

1.4

17.08

15.73

umol/l

—

175

Endometriosis diagnosis and infertility diagnosis occurring together

296

1.39

1.22

1.6

1.3

10.95

9.80

umol/l

0.72

284

Other arthrosis

189

1164

1.16

1.21

1.4

12.17

12.71

umol/l

0.56

176

1109

Benign leiomyoma with endometriosis

348

1.35

1.20

1.6

1.4

11.51

11.25

umol/l

0.10

331

Carcinoma in situ of skin

132

1.60

1.20

2.0

1.6

15.20

14.20

umol/l

0.28

117

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

101

1.69

1.20

1.2

1.5

10.27

10.21

umol/l

0.02

Other acute viral hepatitis

2.32

1.19

1.7

1.6

13.38

10.21

umol/l

—

COPD, hospital admissions 1, only main diagnosis

642

1.23

1.18

1.3

1.4

17.57

14.05

umol/l

2.55

594

Open wound of forearm

239

1.43

1.18

1.2

1.5

12.88

12.98

umol/l

0.03

225

COPD, hospital admissions

124

877

1.20

1.17

1.3

1.4

17.19

13.89

umol/l

2.99

114

817

Cervical disc disorders

124

1039

1.19

1.16

1.4

12.32

12.55

umol/l

0.17

116

982

COPD, early/later onset

125

883

1.20

1.16

1.3

1.4

17.19

13.86

umol/l

3.04

114

823

Other benign neoplasms of connective and other soft tissue

240

1.42

1.15

1.4

1.6

14.21

12.34

umol/l

0.50

221

Other chronic obstructive pulmonary disease, including avohilmo

152

1079

1.17

1.13

1.4

16.25

13.55

umol/l

2.80

140

1014

Fall on same level involving ice and snow

195

1700

1.15

1.13

1.3

1.4

12.01

12.15

umol/l

0.11

182

1609

Habit and impulse disorders

2.01

1.12

1.4

1.8

14.36

11.19

umol/l

—

Parodontitis or/and operation codes

241

1262

1.14

1.12

1.3

1.4

13.40

11.83

umol/l

2.81

223

1204

Mixed disorders of conduct and emotions, excluding more controls

1.97

1.11

1.6

1.7

9.40

10.15

umol/l

—

Non-follicular lymphoma, hilmo, excluding all cancers

192

1.46

1.11

1.5

15.55

13.88

umol/l

0.57

176

Deviated nasal septum

118

989

1.19

1.11

1.2

1.4

12.86

13.10

umol/l

0.16

110

939

Dental pulpitis 2, only avohilmo

293

1336

1.12

1.11

1.4

12.63

12.08

umol/l

0.66

274

1277

Toxic effects of substances chiefly nonmedicinal as to source

319

1.35

1.11

1.2

1.5

12.28

11.96

umol/l

0.14

300

Substance use, excluding alcohol

584

1.25

1.09

1.2

1.5

13.93

11.87

umol/l

0.79

560

Sequelae of injuries, of poisoning and of other consequences of external causes

684

1.23

1.07

1.5

1.4

11.53

12.39

umol/l

0.72

652

Motor disorders, excluding more controls

2.17

1.07

1.3

1.7

7.14

9.31

umol/l

—

Preparation and fitting of bite rail to mouth

391

1.31

1.06

1.3

1.5

11.64

11.36

umol/l

0.15

371

Otitis externa, unspecified

296

1.35

1.05

1.1

1.5

12.02

11.71

umol/l

0.09

280

Carcinoma in situ of skin

137

1.54

1.05

2.0

1.5

15.20

14.61

umol/l

0.15

126

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

163

961

1.16

1.05

1.3

1.4

13.93

13.35

umol/l

0.38

154

904

Impacted cerumen

195

1.44

1.04

1.5

12.81

13.79

umol/l

0.37

185

Benign neoplasm: Scapula and long bones of upper limb

2.29

1.03

1.0

1.3

13.94

10.77

umol/l

—

Allergic urticaria

229

1.40

1.03

1.3

1.5

11.26

11.24

umol/l

0.01

214

Postmenopausal osteoporosis with pathological fracture

1.64

1.03

1.3

1.6

14.44

12.65

umol/l

0.32

Family history of certain disabilities and chronic diseases leading to disablement

106

1.61

1.03

1.2

1.5

10.79

9.86

umol/l

0.45

100

Non-follicular lymphoma

196

1.43

1.02

1.5

15.55

14.06

umol/l

0.49

183

Diabetic retinopathy, excluding more controls

375

1.23

1.01

1.3

1.4

14.14

13.85

umol/l

0.12

346

Other arthritis (FG)

104

872

1.19

1.00

1.3

1.4

12.32

12.06

umol/l

0.20

829

Gonarthrosis,primary

249

1753

0.89

1.00

1.4

13.23

12.96

umol/l

0.25

235

1661

Carpal tunnel syndrome

162

1678

0.87

1.00

1.3

1.4

12.28

12.17

umol/l

0.08

153

1599

Other benign neoplasms of skin

109

902

1.19

0.99

1.3

1.4

12.97

12.65

umol/l

0.15

853

Contraceptive management

166

1015

1.15

0.99

1.4

10.68

11.45

umol/l

1.16

160

975

Hypoplasia of dental enamel, including avohilmo

2.19

0.98

1.0

1.3

10.16

8.00

umol/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

2.19

0.98

1.6

1.7

9.62

10.40

umol/l

—

Colorectal cancer

486

1.26

0.97

1.3

1.4

15.21

14.06

umol/l

0.36

459

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

1.86

0.96

1.2

1.6

15.98

13.30

umol/l

—

Meralgia paraesthetica

1.75

0.96

1.8

1.5

11.22

12.50

umol/l

0.50

Early onset COPD

549

1.24

0.96

1.4

15.47

13.25

umol/l

1.08

517

Vasomotor rhinitis (mode)

198

0.60

0.95

1.0

1.5

10.52

12.31

umol/l

0.70

187

Deficiency of other B group vitamins

1.90

0.94

1.9

13.66

14.13

umol/l

—

Exposure to other specified electric current

2.24

0.93

1.0

1.7

10.50

10.31

umol/l

—

Polyhydramnios

119

0.50

0.93

1.3

1.4

9.50

9.39

umol/l

—

110

Premature separation of placenta [abruptio placentae]

1.74

0.92

1.7

1.4

11.22

9.44

umol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

461

1.24

0.92

1.3

1.4

18.56

14.39

umol/l

2.12

426

Nontoxic goitre/thyroid nodule

725

1.20

0.92

1.3

1.4

10.70

12.28

umol/l

1.70

687

Acute gastritis

167

1.44

0.92

1.5

1.6

15.86

13.04

umol/l

0.69

158

Medical abortion

228

1105

1.12

0.91

1.4

10.53

10.84

umol/l

0.37

215

1059

Other demyelinating diseases of the central nervous system

110

1.55

0.90

1.1

1.5

11.17

10.39

umol/l

0.22

102

Disorders of orbit

102

1.57

0.90

1.1

1.5

10.52

11.68

umol/l

0.33

Poisoning by medicine

682

1.20

0.89

1.3

1.4

12.08

11.57

umol/l

0.22

654

Rotator cuff syndrome

207

1369

1.12

0.89

1.4

12.57

12.83

umol/l

0.22

196

1297

Hypertensive heart and/or renal disease

387

1.24

0.89

1.4

1.5

17.31

13.41

umol/l

2.43

362

Other and unspecified disorders of skin and subcutaneous tissue

155

0.58

0.88

1.0

1.5

12.29

12.85

umol/l

—

147

Impotence

119

1.52

0.88

1.4

1.6

14.55

14.05

umol/l

0.10

112

COPD, hospital admission 2, with asthma infections

598

1.20

0.87

1.3

1.4

17.36

14.05

umol/l

1.96

557

Transport accidents

166

1297

1.14

0.87

1.3

1.4

12.19

11.57

umol/l

0.60

158

1242

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

135

805

1.15

0.87

1.3

1.4

14.20

13.44

umol/l

0.47

129

756

Papulosquamous disorders

128

1110

1.15

0.86

1.4

12.28

12.41

umol/l

0.07

122

1056

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

522

1.23

0.85

1.2

1.4

11.62

11.36

umol/l

0.08

498

Fracture of neck

120

1.50

0.85

1.2

1.5

12.08

13.52

umol/l

0.54

111

Other disorders involving the immune mechanism, not elsewhere classified

1.67

0.85

1.2

1.4

13.25

13.65

umol/l

0.06

Other and unspecified iridocyclitis

104

1.54

0.84

1.1

1.5

10.94

12.24

umol/l

0.66

Disorders of muscles

256

1.33

0.84

1.4

1.5

11.63

12.56

umol/l

0.42

241

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

131

784

1.15

0.84

1.3

1.4

14.33

13.43

umol/l

0.57

125

735

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

100

853

1.17

0.84

1.4

1.5

13.65

12.36

umol/l

0.87

810

Benign lipomatous neoplasm

770

1.18

0.84

1.4

1.5

11.98

12.66

umol/l

0.48

731

Dental caries 2, only avohilmo

303

2182

1.10

0.83

1.3

1.4

10.87

11.53

umol/l

1.19

283

2076

Rare circulating lymphoid malignancy

1.76

0.83

1.2

1.7

15.98

15.14

umol/l

—

Sensorineural hearing loss

199

1556

0.89

0.83

1.4

12.04

13.16

umol/l

2.07

190

1472

Leiomyoma of uterus

159

788

1.14

0.82

1.4

10.49

11.00

umol/l

0.53

152

752

Burn and corrosion of wrist and hand

1.55

0.81

1.3

1.7

13.89

12.03

umol/l

0.36

Other lesions of median nerve

1.71

0.80

1.1

1.7

12.75

12.34

umol/l

—

Other blood glucose lowering drugs, excl. Insulins

365

1.26

0.79

1.2

1.5

14.25

13.25

umol/l

0.33

352

Malignant neoplasm of corpus uteri

147

0.61

0.79

1.0

1.6

10.21

12.33

umol/l

—

138

Fibroblastic disorders

555

1.21

0.79

1.3

1.4

11.96

13.29

umol/l

0.87

522

Behavioural disorders, excluding more controls

1.67

0.78

1.3

1.5

9.76

10.94

umol/l

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

216

1.34

0.78

1.2

1.5

14.09

14.08

umol/l

0.00

201

Other appendicitis

234

0.68

0.77

1.4

1.5

11.81

12.53

umol/l

0.13

222

Other intervertebral disc disorders

317

1782

1.09

0.77

1.4

12.63

12.17

umol/l

0.53

299

1693

Coxibs

121

559

1.15

0.76

1.4

11.66

13.19

umol/l

1.86

115

528

Sub-endpoint used in defining T1D endpoints

101

856

1.16

0.76

1.4

12.65

12.32

umol/l

0.16

814

Disorders of speech understanding and production

105

1.50

0.76

1.1

1.6

12.02

10.15

umol/l

0.50

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

1.70

0.75

1.4

1.6

12.22

15.00

umol/l

—

Lumbar disc prolapse

234

1689

1.10

0.75

1.3

1.4

12.72

12.13

umol/l

0.59

223

1607

Conductive and sensorineural hearing loss

220

1681

0.91

0.75

1.4

11.98

12.97

umol/l

1.81

211

1589

Coxarthrosis [arthrosis of hip](FG)

166

1070

1.12

0.74

1.4

13.61

13.10

umol/l

0.39

155

1015

Other benign neoplasms of connective and other soft tissue

262

1.30

0.74

1.4

1.5

14.21

12.22

umol/l

0.54

245

Basal cell carcinoma

145

1022

1.13

0.74

1.3

1.4

14.30

13.69

umol/l

0.39

139

953

Lichen sclerosus et atrophicus

227

1.32

0.74

1.5

10.28

11.47

umol/l

0.67

218

Basal cell carcinoma, including avohilmo

149

1040

1.13

0.74

1.3

1.4

14.19

13.67

umol/l

0.32

143

971

Lesion of ulnar nerve

360

1.25

0.74

1.4

1.5

12.07

12.54

umol/l

0.21

339

LSIL lesion of the cervix uteri, vagina or vulva

387

1.24

0.74

1.3

1.4

12.51

9.84

umol/l

1.12

370

Other malignant neoplasms of skin (=non-melanoma skin cancer)

142

991

1.13

0.73

1.3

1.4

14.01

13.73

umol/l

0.15

137

924

Male infertility

160

0.62

0.73

1.6

12.52

12.72

umol/l

—

155

Spinal enthesopathy

1.84

0.73

1.3

1.6

12.80

13.25

umol/l

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

1.67

0.72

1.5

1.7

17.77

14.00

umol/l

—

Allergic rhinitis

116

1006

1.14

0.72

1.3

1.4

9.64

11.11

umol/l

2.99

111

964

Hyperprolactinaemia

1.55

0.72

1.1

1.5

10.51

10.22

umol/l

0.07

Polyarthrosis

407

1.23

0.71

1.3

1.4

11.79

12.82

umol/l

0.58

389

Urethral stricture

117

1.46

0.71

1.3

1.5

16.07

14.53

umol/l

0.28

110

Substance abuse

212

1839

1.10

0.71

1.3

1.4

13.78

12.37

umol/l

1.62

177

1757

Postpartum haemorrhage due to anatomy

264

1.29

0.71

1.6

1.3

9.52

9.08

umol/l

0.27

253

Scissor bite

1.58

0.71

1.3

1.4

11.43

9.66

umol/l

0.21

Varicose veins

191

1302

1.11

0.71

1.3

1.4

13.76

12.76

umol/l

0.99

178

1221

Dental caries 2 and operation codes, only avohilmo

269

1530

1.09

0.70

1.4

10.82

12.11

umol/l

3.45

251

1458

Restless leg syndrome

309

1.26

0.70

1.3

1.5

10.52

12.52

umol/l

1.69

291

Carrier of infectious disease

1.56

0.70

2.1

1.7

10.58

11.47

umol/l

—

Acute bronchiolitis

167

1.35

0.69

1.5

1.4

10.71

10.42

umol/l

0.09

160

Other inflammation of vagina/vulva

1.51

0.69

1.4

8.30

9.45

umol/l

0.56

Complications of labour and delivery

188

1161

0.90

0.69

1.4

1.3

9.80

10.89

umol/l

2.24

178

1108

Kela-code for severe mental illness

131

1161

1.13

0.69

1.3

1.4

12.45

11.87

umol/l

0.37

1116

Malignant neoplasm of liver and intrahepatic bile ducts

1.64

0.68

1.8

1.4

10.89

15.67

umol/l

—

Other renal tubulo-interstitial diseases

1.53

0.68

1.2

1.5

16.96

10.74

umol/l

—

Acute and transient psychotic disorders

364

0.77

0.68

1.1

1.5

11.45

11.84

umol/l

0.16

348

Alcohol abuse, main dg

447

1.21

0.67

1.1

1.5

14.58

12.58

umol/l

0.94

427

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

145

1.38

0.65

1.6

11.67

13.35

umol/l

0.44

132

TMD related operations

485

1.20

0.65

1.3

1.4

11.90

11.43

umol/l

0.27

464

Abnormal findings in secretions and smears from cervix uteri vagina vulva

167

1184

1.11

0.64

1.2

1.4

11.09

10.28

umol/l

0.73

159

1130

Malignant neoplasm of skin

167

1134

1.11

0.64

1.3

1.4

14.04

13.56

umol/l

0.33

160

1062

Contusion of toe(s) with damage to nail

1.73

0.64

1.4

10.40

11.39

umol/l

—

Sciatica+with lumbago

175

1505

1.10

0.64

1.2

1.4

11.80

12.07

umol/l

0.24

167

1431

Injuries to the shoulder and upper arm

298

2318

1.08

0.63

1.4

13.36

12.32

umol/l

1.53

279

2196

Anti-inflammatory and antirheumatic products, non-steroids

137

613

1.12

0.63

1.6

1.4

11.86

13.06

umol/l

1.21

127

581

therapeutic use

1.64

0.62

1.1

1.6

15.10

13.48

umol/l

—

Sexual dysfunction

1.67

0.61

1.4

1.8

14.80

12.30

umol/l

—

Endometriosis of fallopian tube

0.00

0.60

0.0

1.2

—

10.73

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

0.00

0.60

0.0

1.5

—

15.62

—

Mouth breathing

139

1249

1.11

0.60

1.4

12.66

12.52

umol/l

0.09

130

1190

Dental caries 3, only avohilmo

337

1607

1.07

0.59

1.4

12.25

12.07

umol/l

0.20

318

1536

204

1717

1.09

0.59

1.3

1.4

13.90

12.62

umol/l

1.54

175

1639

Carcinoma in situ of cervix uteri

232

0.73

0.59

1.4

11.86

9.72

umol/l

0.52

217

Mental and behavioural disorders due to psychoactive substance use

217

1883

1.09

0.59

1.3

1.4

13.82

12.32

umol/l

1.81

182

1799

Other acute skin changes due to ultraviolet radiation

1.53

0.59

1.5

11.65

13.26

umol/l

0.36

Gonarthrosis

198

1241

0.91

0.58

1.4

13.23

12.66

umol/l

0.57

186

1186

Acute peritonitis

140

1.36

0.58

1.6

1.4

10.94

13.36

umol/l

1.34

131

Brain meningioma, excluding all cancers (controls excluding all cancers)

113

0.62

0.58

1.1

1.6

8.63

12.48

umol/l

—

106

Malignant neoplasm of bladder

112

0.62

0.58

1.4

1.5

13.71

16.26

umol/l

—

102

Alzheimer’s disease (Atypical or mixed)

112

0.62

0.58

1.3

1.4

17.43

17.25

umol/l

—

Venous complications and haemorrhoids in pregnancy

1.49

0.57

1.3

1.4

12.20

9.81

umol/l

—

Melanocytic naevi of scalp and neck

1.49

0.57

1.5

1.7

9.45

12.26

umol/l

—

Biguanides

342

1972

1.07

0.57

1.3

1.4

14.11

12.05

umol/l

5.16

310

1892

Impacted maxillary molar

158

1.33

0.57

1.3

1.5

10.08

9.95

umol/l

0.03

146

Other interventions on the root canals of the tooth

1.67

0.57

1.5

1.6

12.17

11.04

umol/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

207

0.72

0.56

1.1

1.5

15.70

12.89

umol/l

0.41

197

Hyperplasia of prostate

108

546

1.13

0.56

1.4

15.15

14.68

umol/l

0.26

100

520

Asthma/COPD (KELA code 203)

367

2429

1.06

0.56

1.3

1.4

12.62

11.80

umol/l

1.22

344

2305

Postpartum haemorrhage due to retained placenta

352

0.79

0.55

1.2

1.4

10.02

9.31

umol/l

0.55

340

Other diseases of spinal cord

1.54

0.55

1.3

1.6

10.71

12.27

umol/l

—

Lack of expected normal physiological development

1.51

0.54

1.7

12.33

10.14

umol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

228

1961

1.08

0.54

1.3

1.4

11.30

11.79

umol/l

0.80

218

1866

Adenocarcinoma and ductal carcinoma of pancreas

1.50

0.54

1.4

1.6

12.22

15.28

umol/l

—

Spontaneous rupture of synovium and tendon

182

0.71

0.54

2.3

1.5

11.58

12.91

umol/l

0.54

169

Other surgical follow-up care

1.48

0.53

1.1

1.5

10.47

11.34

umol/l

—

Right bundle-branch block

1.48

0.53

1.0

1.4

13.54

13.10

umol/l

—

Corns and callosities

160

1.31

0.53

1.6

12.95

13.16

umol/l

0.07

153

severe traumatic brain injury, does not include concussion

497

1.17

0.53

1.5

1.4

12.75

13.85

umol/l

0.73

463

L02BX Other hormone antagonists and related agents

0.62

0.52

1.3

1.4

16.90

16.34

umol/l

—

Pustulosis palmaris et plantaris

0.61

0.52

1.2

1.5

13.40

11.77

umol/l

—

Impetigo

126

1.35

0.51

1.4

1.5

11.96

11.31

umol/l

0.16

117

Idiopathic pulmonary fibrosis

126

1.35

0.51

1.2

1.5

14.60

15.41

umol/l

0.14

116

Other benign neoplasms of skin

109

979

1.11

0.51

1.3

1.4

12.97

12.60

umol/l

0.18

927

Erythema nodosum

1.39

0.50

1.2

1.6

12.88

11.62

umol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

194

1462

1.08

0.50

1.3

1.4

11.25

11.20

umol/l

0.03

185

1389

Mandibular retrognathia AND surgery (BSSRO)

1.50

0.49

1.1

1.4

10.06

10.14

umol/l

—

Bilateral sagittal split ramus osteotomy operation

1.43

0.49

1.5

1.4

9.42

10.28

umol/l

0.35

Coxarthrosis

153

949

1.09

0.49

1.4

13.62

13.20

umol/l

0.29

143

906

Glaucoma-related operations

110

1.37

0.48

1.0

1.5

12.11

14.92

umol/l

0.65

104

Other neurotic disorders

110

1.37

0.48

1.2

1.5

13.83

13.52

umol/l

0.04

104

Diseases of middle ear and mastoid

219

1668

1.08

0.48

1.3

1.4

11.30

11.47

umol/l

0.17

206

1586

Carcinoma in situ of cervix uteri

223

0.76

0.48

1.4

11.86

9.92

umol/l

0.46

209

Vasomotor and allergic rhinitis

137

1232

1.10

0.48

1.3

1.4

10.27

11.50

umol/l

2.04

132

1173

Brain meningioma

111

0.63

0.48

1.1

1.5

8.63

13.23

umol/l

—

105

Vascular syndromes of brain in cerebrovascular disorders

1.45

0.48

1.5

1.4

13.76

15.96

umol/l

0.44

Fall on and from ladder

172

1.28

0.48

1.3

1.5

12.89

14.27

umol/l

0.38

160

Nail disorders

235

1.24

0.48

1.5

11.80

12.08

umol/l

0.12

222

Artificial joint operation, meniscal resection

281

1990

0.94

0.47

1.4

12.53

12.82

umol/l

0.32

268

1887

Burn and corrosion of hip and lower limb, except ankle and foot

1.46

0.47

1.4

1.8

9.17

12.11

umol/l

—

Fall involving bed

1.46

0.47

1.9

1.5

17.71

15.83

umol/l

—

Alcohol dependence

787

1.12

0.46

1.3

1.4

14.75

13.09

umol/l

1.01

753

Adenocarcinoma of pancreas

1.40

0.45

1.4

1.8

12.14

15.78

umol/l

—

Open wound of wrist and hand

135

1456

0.92

0.44

1.3

1.4

11.49

12.32

umol/l

0.88

130

1377

D07AA Corticosteroids, weak (group I)

459

1.15

0.44

1.5

11.85

11.42

umol/l

0.15

436

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

131

821

1.09

0.44

1.3

1.4

14.20

13.41

umol/l

0.49

125

771

Autism spe, excluding more controls

1.38

0.44

2.1

1.7

10.21

9.63

umol/l

—

Chronic nephritic syndrome

1.37

0.43

1.1

1.6

16.62

12.73

umol/l

0.72

Asthma and opportunity respiratory infection

1.37

0.43

1.2

1.5

14.98

14.23

umol/l

0.13

Inflammatory disease of cervix uteri

163

0.73

0.43

1.7

1.4

9.98

10.88

umol/l

0.42

154

Maternal care for known or suspected disproportion

128

0.70

0.43

1.6

1.3

7.93

9.65

umol/l

—

119

Allergic purpura

1.41

0.43

1.3

1.6

14.70

12.25

umol/l

0.61

Mental and behavioural disorders due to alcohol

175

1582

1.08

0.43

1.3

1.4

13.98

12.52

umol/l

1.73

147

1511

Acute nasopharyngitis (common cold)

369

0.83

0.42

1.7

1.5

10.94

12.17

umol/l

1.21

358

Diabetic neuropathy

265

1.20

0.42

1.1

1.4

13.76

14.61

umol/l

0.19

245

Diffuse large B-cell lymphoma, helper endpoint

1.38

0.42

1.3

1.5

20.10

13.81

umol/l

2.01

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1.38

0.42

1.3

1.5

20.10

13.81

umol/l

2.01

Other obstetric trauma

140

1.29

0.42

1.4

1.3

11.02

9.64

umol/l

0.64

132

Ingrowing nail

158

1.27

0.41

1.8

1.5

11.55

12.24

umol/l

0.25

148

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.41

0.0

1.7

—

13.54

—

Other drug-induced secondary parkinsonism

0.00

0.41

0.0

2.2

—

12.91

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

1.39

0.40

1.1

1.7

14.99

14.07

umol/l

0.11

Poisoning by drugs, medicaments and biological substances

757

1.11

0.40

1.2

1.4

12.04

11.43

umol/l

0.28

727

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.40

0.0

2.6

—

8.64

—

Xanthelasma of eyelid

0.00

0.40

0.0

2.2

—

10.83

—

Other and unspecified injuries of neck

0.00

0.40

0.0

1.8

—

10.15

—

Deep endometriosis

249

0.80

0.40

1.2

1.5

9.58

10.89

umol/l

0.67

234

Diffuse large B-cell lymphoma

1.37

0.40

1.3

1.6

20.10

14.55

umol/l

1.71

Polycythaemia vera

1.31

0.39

1.0

1.7

9.76

13.98

umol/l

—

Viral meningitis

1.34

0.39

1.2

1.6

13.33

10.39

umol/l

0.85

Artrosis, including avohilmo

301

1742

0.95

0.39

1.4

12.36

umol/l

0.00

283

1665

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.5

—

15.35

—

Dental operations, only avohilmo

272

1316

1.06

0.39

1.4

12.61

12.46

umol/l

0.13

256

1248

Other congenital malformations of skin

115

1.31

0.39

1.0

1.5

7.44

11.06

umol/l

4.26

109

Dislocation, sprain and strain of joints and ligaments of thorax

1.38

0.38

2.1

1.7

12.05

12.29

umol/l

0.03

Benign neoplasm: Conjunctiva

1.37

0.38

1.1

1.6

11.89

13.18

umol/l

—

Disorders of synovium and tendon

177

1490

1.07

0.38

1.5

1.4

10.64

12.11

umol/l

3.92

168

1414

Foreign body on external eye

451

0.86

0.37

1.5

13.71

13.00

umol/l

0.26

428

Palmar fascial fibromatosis [Dupuytren]

327

1.16

0.37

1.3

1.4

13.10

14.15

umol/l

0.33

303

Ankylosing spondylitis, ICD10

253

1.19

0.36

1.4

1.5

11.06

12.04

umol/l

0.62

237

Psoriasis

801

1.10

0.36

1.3

1.4

12.23

12.48

umol/l

0.13

761

212

1789

1.06

0.36

1.3

1.4

13.67

12.53

umol/l

1.36

183

1709

Propionic acid derivatives

132

613

1.08

0.36

1.6

1.4

11.93

13.06

umol/l

1.01

123

581

Umbilical hernia

725

1.10

0.36

1.2

1.4

14.11

12.70

umol/l

0.96

690

Alcohol use disorder, Swedish definition

187

1630

1.07

0.36

1.3

1.4

13.72

12.67

umol/l

1.08

159

1555

Coxarthrosis, primary, with hip surgery

1023

0.92

0.36

1.5

1.4

13.21

13.82

umol/l

0.41

957

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.66

0.35

1.4

1.6

10.44

12.01

umol/l

—

Open bite

157

0.76

0.35

1.3

1.5

7.78

10.07

umol/l

1.79

148

Mental and behavioural disorders due to alcohol, excluding acute intoxication

147

1369

1.07

0.35

1.3

1.4

14.14

12.81

umol/l

1.27

120

1309

Lesion of sciatic nerve

0.63

0.35

2.4

1.5

10.38

13.98

umol/l

—

Benign neoplasm: Skin of eyelid, including canthus

363

0.85

0.35

1.3

1.5

12.25

12.96

umol/l

0.30

341

Injury of muscle and tendon at shoulder and upper arm level

103

947

1.09

0.35

1.5

1.4

12.40

13.38

umol/l

1.04

892

Unknown and unspecified causes of morbidity

154

1.24

0.34

1.1

1.5

13.86

12.04

umol/l

0.32

146

Contact with heat and hot substances

133

0.75

0.33

1.2

1.6

11.33

12.79

umol/l

—

124

Bronchiectasis

164

1.22

0.32

1.3

1.6

14.75

13.40

umol/l

0.33

152

Ectopic pregnancy

492

1.12

0.32

1.1

1.4

9.95

10.50

umol/l

0.28

472

Sulfonylureas

590

1.10

0.32

1.2

1.5

16.60

14.05

umol/l

2.11

563

Postprocedural musculoskeletal disorders, not elsewhere classified

155

1.23

0.32

1.8

1.5

11.96

13.18

umol/l

0.57

146

Single spontaneous delivery

120

688

0.93

0.32

1.6

1.3

10.47

11.18

umol/l

0.69

112

652

Glucosamine medication

113

970

0.93

0.31

1.4

12.50

13.66

umol/l

0.97

104

915

Infections of genitourinary tract in pregnancy

262

0.84

0.31

1.3

1.4

9.78

10.15

umol/l

0.17

248

Unspecified urinary incontinence

202

1.19

0.31

1.3

1.5

11.76

12.06

umol/l

0.11

190

Multiple delivery

272

0.84

0.30

1.4

1.3

9.65

10.62

umol/l

0.54

259

Chondropathies

457

1.12

0.30

1.4

1.5

13.50

11.98

umol/l

0.59

431

Alcohol use disorder, ICD-based

134

1257

1.07

0.29

1.3

1.4

14.31

12.74

umol/l

1.50

110

1200

Specific development disorders of scholastic skills

137

1.23

0.29

1.5

1.4

10.52

10.67

umol/l

0.05

130

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

130

0.77

0.29

1.1

1.5

12.91

10.78

umol/l

—

123

Enthesopathies of lower limb, excluding foot

649

1.09

0.29

1.6

1.5

11.65

11.86

umol/l

0.09

613

Supplementary factors related to causes of morbidity and mortality classified elsewhere

880

1.08

0.29

1.4

12.51

12.37

umol/l

0.05

838

Pustular psoriasis

111

0.72

0.28

1.1

1.5

12.80

12.06

umol/l

—

104

Foreign body or object entering through skin

184

0.81

0.28

1.1

1.5

11.27

12.14

umol/l

0.18

174

Primary gonarthrosis, bilateral

122

1139

0.94

0.28

1.5

1.4

13.01

13.39

umol/l

0.27

116

1074

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

1.32

0.28

1.2

1.6

14.98

13.64

umol/l

—

Disturbances of smell and taste

1.28

0.28

1.3

1.4

11.44

11.92

umol/l

0.11

Congenital malformations of uterus and cervix

1.27

0.28

1.3

1.7

7.18

10.04

umol/l

—

Dental caries 1, only avohilmo

310

1522

1.04

0.27

1.4

12.36

12.18

umol/l

0.17

291

1454

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

116

0.77

0.27

1.4

1.5

12.38

11.68

umol/l

—

110

1.29

0.27

1.1

1.6

14.28

14.36

umol/l

0.01

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

243

1.15

0.26

1.2

1.5

14.19

14.00

umol/l

0.04

225

Malignant neoplasm of pancreas

113

1.24

0.26

1.5

11.31

14.92

umol/l

1.11

106

Degenerative diseases of the nervous system

448

1.09

0.26

1.5

1.4

13.83

15.23

umol/l

0.59

416

Malignant neoplasm of prostate

585

0.93

0.26

1.4

14.53

15.46

umol/l

0.60

543

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

137

1268

0.94

0.25

1.3

11.23

10.35

umol/l

1.09

132

1208

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

192

0.83

0.25

1.2

1.4

15.90

14.41

umol/l

0.26

179

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

235

1.15

0.25

1.1

1.5

12.21

11.66

umol/l

0.09

224

Schizoaffective disorder

234

0.85

0.24

1.1

1.6

14.86

11.70

umol/l

—

224

Trigeminal neuralgia

142

1.20

0.24

1.4

1.5

12.14

12.36

umol/l

0.06

134

Caught, crushed, jammed or pinched in or between objects

133

1.20

0.24

1.4

1.5

10.16

12.24

umol/l

1.57

125

0.73

0.24

1.2

1.6

11.55

9.46

umol/l

—

Diabetic retinopathy

561

1.07

0.23

1.4

14.00

14.39

umol/l

0.20

514

Ankylosing spondylitis

265

1.13

0.23

1.4

1.5

11.06

12.25

umol/l

0.82

248

Atopic conjunctivitis

106

1.23

0.23

1.5

1.6

11.90

10.48

umol/l

0.45

Wide developmental disorders, excluding more controls

1.27

0.22

1.8

1.6

10.55

10.24

umol/l

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

1.25

0.22

1.8

1.6

12.19

14.09

umol/l

0.26

Macular pucker

285

1.12

0.22

1.4

1.5

13.43

14.12

umol/l

0.19

266

Follicular lymphoma

0.77

0.22

1.3

1.6

14.91

13.32

umol/l

—

Hydatidiform mole

1.25

0.22

1.2

1.6

7.06

10.72

umol/l

—

Plantar fascial fibromatosis

238

1.14

0.22

1.3

1.4

10.86

12.07

umol/l

0.70

228

Fracture of foot, except ankle

719

1.07

0.22

1.3

1.4

11.80

12.00

umol/l

0.11

688

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.6

—

14.01

—

Abnormal reflex

0.00

0.21

0.0

1.4

—

10.10

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.5

—

10.09

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.5

—

12.50

—

Lower leg

0.00

0.21

0.0

1.5

—

10.90

—

Cicatricial alopecia [scarring hair loss]

0.00

0.21

0.0

1.6

—

9.81

—

0.00

0.21

0.0

1.7

—

9.99

—

Glaucoma

133

1227

0.95

0.21

1.4

12.12

13.60

umol/l

2.07

126

1155

Gonarthrosis [arthrosis of knee](FG)

236

1442

0.96

0.21

1.4

13.15

12.57

umol/l

0.66

223

1372

Other dermatomyositis

0.00

0.21

0.0

1.6

—

12.92

—

Cervical root disorders

0.00

0.21

0.0

2.2

—

11.14

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.5

—

10.92

—

Type of accident

788

1.07

0.21

1.4

12.23

12.46

umol/l

0.10

748

Hyperfunction of pituitary gland

126

1.19

0.21

1.1

1.5

10.04

10.66

umol/l

0.20

117

Deformity of finger(s)

0.00

0.21

0.0

1.5

—

10.52

—

Other enthesopathies

828

1.06

0.20

1.2

1.4

11.66

12.11

umol/l

0.36

785

malignant neoplasm of male genital organs

620

0.94

0.20

1.4

14.82

15.20

umol/l

0.18

576

Later onset COPD

414

1.08

0.20

1.2

1.5

19.33

15.30

umol/l

2.03

381

Adenocarcinoma and papilloma adenocarcinoma of rectum

187

0.85

0.20

1.2

1.4

15.90

14.41

umol/l

0.26

174

Melanocytic naevi of other and unspecified parts of face

155

0.84

0.20

1.2

1.4

9.83

11.58

umol/l

0.53

146

Oral lichen ruber planus wide, hypothyreosis or thyroxin

114

0.79

0.20

1.2

1.6

8.73

11.96

umol/l

—

106

Suggestive for eosinophilic asthma

229

0.87

0.20

1.1

1.5

13.42

13.18

umol/l

0.05

217

Other and unspecified tonsillitis

134

1084

1.05

0.20

1.4

11.19

umol/l

0.00

127

1043

Carcinoma in situ of skin of trunk

1.18

0.19

1.2

1.6

13.67

15.67

umol/l

—

Benign neoplasm: Descending colon

137

1.17

0.18

1.3

1.6

15.02

13.90

umol/l

0.23

124

Pregnancy, childbirth and the puerperium

466

0.94

0.18

1.4

1.3

11.21

11.25

umol/l

0.02

444

Salpingitis and oophoritis

455

1.08

0.17

1.6

1.4

11.62

10.98

umol/l

0.26

434

Other maternal disorders predominantly related to pregnancy

197

1196

1.04

0.17

1.4

1.3

10.59

10.53

umol/l

0.04

188

1144

0.72

0.17

1.2

1.6

12.46

8.73

umol/l

—

Melanocytic naevi of other and unspecified parts of face

152

0.85

0.17

1.2

1.5

9.83

11.58

umol/l

0.53

141

Delivery, wide proxy

101

564

0.95

0.16

1.5

1.3

11.12

11.09

umol/l

0.02

532

Placenta praevia

120

1.17

0.16

1.5

1.4

10.59

9.13

umol/l

0.62

111

Benign neoplasm of other and unspecified sites

1.14

0.16

1.3

1.5

9.43

12.31

umol/l

—

Malignant neoplasm of head and neck

177

1.13

0.16

1.1

1.5

14.91

14.45

umol/l

0.08

164

Benign neoplasm of other and unspecified sites

1.11

0.16

1.3

1.6

9.42

12.03

umol/l

—

Benign neoplasm of thyroid gland

1.11

0.16

1.0

1.5

10.29

11.71

umol/l

—

Benign neoplasm of thyroid gland

1.11

0.16

1.0

1.6

10.29

12.98

umol/l

—

Complications predominantly related to the puerperium

789

0.95

0.14

1.4

9.03

10.33

umol/l

1.17

759

Gestational diabetes (for exclusion)

119

876

0.96

0.14

1.4

1.3

9.06

9.77

umol/l

1.28

113

845

Primary open-angle glaucoma

628

1.06

0.14

1.4

13.07

14.28

umol/l

0.72

588

Sacroiliitis, not elsewhere classified

131

1.15

0.14

1.3

1.5

10.86

10.70

umol/l

0.04

122

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.19

0.14

1.2

1.6

14.98

14.42

umol/l

—

Delivery

126

692

0.96

0.14

1.6

1.3

10.50

11.19

umol/l

0.63

117

656

Other and unspecified injuries of wrist and hand

100

0.80

0.13

1.1

1.5

12.00

11.58

umol/l

—

Arthrosis

247

1392

0.98

0.13

1.4

12.40

12.39

umol/l

0.01

231

1332

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

113

1.15

0.13

1.6

18.73

12.50

umol/l

0.79

108

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

113

1.15

0.13

1.6

1.5

18.73

12.67

umol/l

0.76

107

Impingement syndrome of shoulder

632

0.95

0.13

1.4

13.00

12.86

umol/l

0.06

599

Benign neoplasm: Descending colon

142

1.13

0.12

1.3

1.5

15.02

14.06

umol/l

0.19

134

Leiomyoma of uterus

195

1079

1.03

0.12

1.4

1.3

10.87

11.16

umol/l

0.24

184

1033

Maternal care related to the fetus and amniotic cavity and possible delivery problems

158

903

1.03

0.12

1.3

9.65

10.23

umol/l

0.88

153

862

Other juvenile arthritis

116

0.86

0.12

1.4

1.5

10.60

9.95

umol/l

—

109

Acute appendicitis

250

2307

1.02

0.11

1.3

1.4

12.19

11.80

umol/l

0.44

241

2187

Follicular cysts of skin and subcutaneous tissue

497

0.95

0.11

1.2

1.5

13.38

12.61

umol/l

0.30

473

Other disorders of ear

303

2058

0.98

0.11

1.4

12.18

12.48

umol/l

0.34

285

1952

Other disorders of male genital organs

105

1.14

0.11

1.8

1.6

13.63

13.66

umol/l

0.00

100

Other and unspecified glaucoma

115

1.13

0.10

1.2

1.4

12.25

14.95

umol/l

1.03

104

Recurrent dislocation of patella

144

1.11

0.10

1.2

1.5

14.19

10.07

umol/l

0.94

135

Suicide or other Intentional self-harm

772

1.04

0.09

1.2

1.4

11.84

11.71

umol/l

0.05

740

Diseases of appendix

267

2390

1.02

0.09

1.3

1.4

12.19

11.85

umol/l

0.38

258

2267

Appendectomy

230

2174

1.02

0.09

1.3

1.4

11.38

11.67

umol/l

0.31

221

2068

Pediculosis, acariasis and other infestations

155

0.90

0.09

1.3

1.6

13.22

12.39

umol/l

0.29

148

Carcinoma in situ of skin of trunk

1.09

0.09

1.2

1.5

13.67

15.17

umol/l

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.09

0.09

1.8

1.7

18.17

14.16

umol/l

—

Crossbite

198

1.08

0.08

1.2

1.5

10.27

10.76

umol/l

0.15

190

Other specified/unspecified hearing loss

175

0.91

0.08

1.6

1.5

14.11

13.32

umol/l

0.14

167

Internal derangement of knee

116

1186

0.98

0.08

1.3

1.4

11.27

12.14

umol/l

1.09

110

1134

Suppurative and unspecified otitis media

133

1152

1.02

0.08

1.3

1.4

10.69

11.19

umol/l

0.51

126

1094

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

467

0.97

0.08

1.4

1.5

14.94

14.92

umol/l

0.01

433

Acute suppurative otitis media

902

0.97

0.08

1.4

10.57

10.93

umol/l

0.34

854

Effects of other external causes

0.83

0.07

1.0

1.6

9.13

11.77

umol/l

—

Primary angle-closure glaucoma

0.86

0.07

1.6

1.5

13.24

15.38

umol/l

—

Follicular lymphoma, hilmo

0.82

0.07

1.3

1.5

14.91

14.79

umol/l

—

Appendicitis, broad definition

264

2380

1.01

0.07

1.3

1.4

12.22

11.83

umol/l

0.44

255

2257

Benign neoplasm: Long bones of lower limb

0.89

0.06

1.0

1.6

9.65

12.05

umol/l

—

Benign neoplasm: Long bones of lower limb

0.85

0.06

1.0

1.6

9.65

12.01

umol/l

—

Diseases of male genital organs

191

950

1.02

0.06

1.4

14.44

13.38

umol/l

1.23

178

899

Ganglion

589

0.97

0.06

1.4

10.16

11.84

umol/l

1.68

558

Benign neoplasm: Skin of trunk

102

0.88

0.06

1.4

1.6

13.23

12.23

umol/l

—

Primary open-angle glaucoma, strict

511

1.04

0.06

1.4

11.74

14.41

umol/l

2.51

477

Benign neoplasm: Skin of trunk

104

0.86

0.06

1.4

1.5

13.23

12.26

umol/l

—

Mental and behavioural disorders due to sedatives or hypnotics

197

1.07

0.06

1.0

1.5

13.37

12.05

umol/l

0.25

188

Benign neoplasm: Skin of eyelid, including canthus

325

0.95

0.06

1.3

1.5

12.25

13.16

umol/l

0.41

304

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

100

978

1.02

0.06

1.2

1.4

11.01

11.22

umol/l

0.10

938

Juvenile osteochondrosis

1.11

0.05

1.2

1.5

11.75

10.93

umol/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

425

0.97

0.05

1.3

1.4

14.49

15.21

umol/l

0.37

394

Acute appendicitis, no complications

197

1940

1.01

0.05

1.3

1.4

12.07

11.61

umol/l

0.48

189

1841

Dental pulpitis 1, only avohilmo

430

2262

0.99

0.04

1.3

1.4

12.91

11.90

umol/l

2.09

400

2153

LSIL lesion of the cervix uteri

298

1.04

0.04

1.2

1.4

10.23

9.90

umol/l

0.09

284

Arthropod-borne viral fevers and viral haemorrhagic fevers

241

0.95

0.04

1.1

1.5

14.75

12.88

umol/l

0.40

224

Effects of foreign body entering through natural orifice

745

1.02

0.04

1.5

13.78

12.44

umol/l

0.93

711

Other and unspecified nerve root and plexus disorders, also in other diseases

513

0.97

0.04

1.4

13.63

12.21

umol/l

0.54

486

Generalized epilepsy

119

0.92

0.04

1.0

1.6

9.62

11.61

umol/l

0.49

110

Inguinal hernia

199

1328

1.01

0.03

1.4

13.00

12.97

umol/l

0.02

187

1254

Acute alcohol intoxication

726

1.02

0.03

1.1

1.5

14.66

12.92

umol/l

1.02

693

Poor fetal growth

359

1.03

0.03

1.3

10.24

9.32

umol/l

0.56

341

Malignant neoplasm of rectum

189

0.95

0.03

1.2

1.4

15.75

14.42

umol/l

0.26

176

Amblyopia ex anopsia

102

1.08

0.03

1.1

1.5

11.20

11.11

umol/l

0.02

Scabies

112

1.07

0.03

1.3

1.7

12.51

12.30

umol/l

0.05

106

Labour and delivery complicated by umbilical cord complications

132

1.06

0.02

1.1

1.4

13.13

10.29

umol/l

0.87

124

Endovascular or surgical operations to intracerebral aneurysms

132

1.06

0.02

1.1

1.6

10.11

13.39

umol/l

2.02

126

Coxarthrosis, primary

149

1282

1.01

0.02

1.4

13.46

13.47

umol/l

0.00

139

1205

LeFortI or BSSRO operation

113

1.06

0.02

1.5

9.42

10.39

umol/l

0.41

106

Dental pulpitis 4, only avohilmo

433

2253

1.00

0.01

1.3

1.4

12.94

11.89

umol/l

2.23

402

2145

Other and unspecified injuries of lower leg

193

1.04

0.01

1.6

1.5

13.16

11.54

umol/l

0.61

185

Acute alcohol intoxication, ICD10

582

1.01

0.01

1.1

1.5

13.59

12.55

umol/l

0.55

556

Pregnancy with abortive outcome

212

1114

1.00

0.01

1.2

1.4

10.62

10.85

umol/l

0.21

201

1068

Tonsillectomy and adenotomy

228

1581

1.00

0.01

1.3

1.4

10.09

11.04

umol/l

2.38

219

1504

Dental caries 1 and operation codes, only avohilmo

105

532

0.99

0.01

1.4

11.83

12.22

umol/l

0.21

100

513

Acetic acid derivatives and related substances

106

548

1.01

0.01

1.3

1.4

12.33

13.23

umol/l

0.58

519

Injuries to the wrist and hand

362

2616

1.00

0.01

1.4

12.13

11.92

umol/l

0.26

347

2480

Dental caries 3 and operation codes, only avohilmo

123

614

1.01

0.00

1.5

1.4

11.37

11.86

umol/l

0.32

117

592

Struck by thrown, projected or falling objec

136

0.96

0.00

1.2

1.6

10.87

12.85

umol/l

0.84

128

Contact with other sharp object(s)

186

0.97

0.00

1.1

1.5

10.34

12.03

umol/l

1.12

178

Exposure to other and unspecified inanimate mechanical forces

186

0.97

0.00

1.5

1.6

11.83

12.04

umol/l

0.06

176

Certain conditions originating in the perinatal period

262

0.98

0.00

1.3

1.4

11.59

10.18

umol/l

0.36

247

Oter anti-inflammatory and antirheumatic agents, non-steroids

385

1.01

0.00

1.6

1.4

12.37

13.99

umol/l

1.21

369

Spontaneous abortion

146

989

1.00

0.00

1.3

1.4

10.33

10.56

umol/l

0.18

139

948

Dislocation, sprain and strain of joints and ligaments of elbow

165

0.97

0.00

1.3

1.5

13.06

11.24

umol/l

0.47

156

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

203

0.98

0.00

1.2

1.5

15.62

14.16

umol/l

0.33

187

Other and unspecified mood [affective] disorders

199

1.01

0.00

1.1

1.5

11.17

10.60

umol/l

0.15

193

Schizophrenia

515

1.01

0.00

1.1

1.5

13.40

12.23

umol/l

0.36

492

Meniscus derangement

187

1279

1.00

0.00

1.5

1.4

11.73

12.59

umol/l

1.36

180

1222

Calculus of lower urinary tract

104

0.96

0.00

1.1

1.5

12.74

14.61

umol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

112

0.98

0.00

1.5

1.4

8.69

10.23

umol/l

1.09

107

Other abnormal findings of blood chemistry

108

1.02

0.00

1.3

1.6

12.83

12.27

umol/l

0.09

102

Contact with sharp glass

112

0.98

0.00

1.3

1.6

9.86

11.45

umol/l

0.53

106

Artificial joint re-operation

142

0.99

0.00

1.6

16.65

14.02

umol/l

0.47

132

Pyogenic arthritis

155

1.03

0.00

1.1

1.5

13.25

13.34

umol/l

0.02

146

Other hammer toe(s) (acquired)

346

1.00

0.00

1.2

1.4

12.70

12.99

umol/l

0.11

328

Redundant prepuce, phimosis and paraphimosis

654

1.00

0.00

1.2

1.4

13.96

12.83

umol/l

0.65

615

Juvenile arthritis (FINNGEN)

127

1.02

0.00

1.3

1.4

10.25

9.68

umol/l

0.15

120

Disorders of continuity of bone

263

0.99

0.00

1.3

1.5

12.38

12.06

umol/l

0.11

248

Endometriosis of rectovaginal septum and vagina

173

0.98

0.00

1.2

1.3

9.15

11.14

umol/l

1.15

165

Injury of nerves at wrist and hand level

105

0.95

0.00

1.3

1.6

12.80

13.04

umol/l

—

100

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

199

1.00

0.00

1.2

1.5

15.62

14.19

umol/l

0.32

183

Frontotemporal dementia

0.00

0.0

1.7

—

14.76

—

Use of peginterferon beta-1a

0.00

0.0

1.8

—

8.28

—

Necrobiosis lipoidica, not elsewhere classified

0.00

0.0

1.3

—

12.00

—

Transient acantholytic dermatosis [Grover]

0.00

0.0

1.8

—

16.18

—

Burn and corrosion of other internal organs

0.00

0.0

1.4

—

10.20

—

Erythema annulare centrifugum

0.00

0.0

1.8

—

16.18

—

Operations 1 for CAVS

0.00

0.0

2.0

—

17.02

—

Pneumonia due to Haemophilus influenzae

0.00

0.0

2.0

—

16.52

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.0

1.3

—

10.83

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.0

1.5

—

13.00

—

Disorders of puberty, other/unspecified

0.00

0.0

1.6

—

9.11

—

Drug-induced aplastic anaemia

0.00

0.0

1.2

—

12.33

—

Melanoma in situ of scalp and neck

0.00

0.0

2.1

—

15.73

—

Congenital myopathies

0.00

0.0

1.2

—

9.17

—

Sequelae of transport accidents

0.00

0.0

1.8

—

9.20

—

Epileptic seizures related to drugs

0.00

0.0

1.3

—

11.00

—

Benign neoplasm: Heart

0.00

0.0

1.3

—

11.29

—

Choroidal detachment

0.00

0.0

1.8

—

11.35

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.0

1.7

—

13.89

—

Sleep terrors [night terrors]

0.00

0.0

2.2

—

11.33

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.2

—

12.00

—

Exposure to ignition of highly flammable material

0.00

0.0

1.8

—

9.83

—

Sleepwalking [somnambulism]

0.00

0.0

1.3

—

10.86

—

Retarded development following protein-energy malnutrition

0.00

0.0

1.6

—

10.00

—

Discharge from other and unspecified firearms

0.00

0.0

1.5

—

10.00

—

Exposure to excessive natural heat

0.00

0.0

1.3

—

10.67

—

Contact urticaria

0.00

0.0

1.4

—

8.00

—

Accidental poisoning by and exposure to pesticides

0.00

0.0

1.8

—

10.33

—

Adrenogenital disorders

0.00

0.0

2.0

—

20.83

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.0

3.0

—

23.02

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.0

1.2

—

10.00

—

Secondary sideroblastic anaemia

0.00

0.0

2.2

—

17.02

—

Other specified/unspecified disorders of ear

0.00

0.0

1.9

—

11.01

—

Factitial dermatitis

0.00

0.0

1.8

—

15.52

—

Chronic myringitis

0.00

0.0

1.2

—

12.67

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.0

1.6

—

12.14

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.0

1.4

—

9.20

—

Vaginal lichen planus

0.00

0.0

1.4

—

11.54

—

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

0.0

2.2

—

13.17

—

Immunodeficiency associated with other major defects

0.00

0.0

1.5

—

10.17

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

1.7

—

9.00

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.2

—

14.40

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.6

—

14.40

—

Interstitial cystitis (chronic), drug-induced

0.00

0.0

1.6

—

15.01

—

Open wound of hip and thigh

0.89

0.00

1.6

1.7

11.00

11.92

umol/l

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.0

1.8

—

17.68

—

Abscess of Bartholin gland

1.00

0.00

1.7

1.4

9.79

9.57

umol/l

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.5

—

11.67

—

Malignant neoplasm of other and unspecified urinary organs

0.00

0.0

1.8

—

23.62

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.2

—

12.20

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.4

—

11.00

—

Malignant neoplasm of ureter

0.00

0.0

1.7

—

18.85

—

Airway disease due to specific organic dust

0.00

0.0

1.5

—

9.67

—

Renal cell carcinoma of kidney

0.92

0.00

1.8

1.6

18.17

14.79

umol/l

—

Labyrinthine fistula

0.00

0.0

1.8

—

12.35

—

Malignant neoplasm, without specification of site

0.94

0.00

1.0

1.6

13.76

16.03

umol/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.88

0.00

1.3

17.43

15.86

umol/l

—

Multiple superficial injuries of ankle and foot

0.00

0.0

1.3

—

9.17

—

Personal history of allergy to analgesic agent

0.00

0.0

1.7

—

11.17

—

Carcinoma in situ of endometrium

0.00

0.0

1.9

—

14.49

—

Enteropathogenic Escherichia coli infection

0.00

0.0

1.2

—

11.80

—

Maxillary prognathism

0.00

0.0

1.7

—

9.22

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.7

—

18.85

—

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

1.2

—

17.80

—

Mucinous and mucinous cystic tumor

0.00

0.0

1.5

—

10.85

—

Psoas tendinitis

0.00

0.0

1.4

—

10.71

—

Injury of blood vessels of thorax

0.00

0.0

1.9

—

15.01

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.7

—

14.01

—

Meningitis, viral

0.00

0.0

1.9

—

14.87

—

Malignant neoplasm of penis

0.00

0.0

1.2

—

12.80

—

Other acantholytic disorders

0.00

0.0

1.7

—

15.87

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.6

—

11.60

—

Fat embolism (traumatic)

0.00

0.0

2.0

—

17.62

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.93

0.00

1.0

1.6

12.64

13.27

umol/l

—

Congenital malformations of ear causing impairment of hearing

0.00

0.0

1.8

—

9.17

—

Benign neoplasm: Skin, unspecified

0.93

0.00

1.0

1.5

15.82

12.32

umol/l

—

Lichenoid drug reaction

0.00

0.0

1.2

—

13.00

—

Photocontact dermatitis [berloque dermatitis]

0.00

0.0

2.0

—

17.62

—

Other specified/unspecified disorders of tympanic membrane

0.00

0.0

1.9

—

10.50

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

11.60

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.0

2.3

—

14.13

—

Hair colour and hair shaft abnormalities

0.00

0.0

1.6

—

13.71

—

Toxic erythema

0.00

0.0

1.3

—

13.17

—

Infections of breast associated with childbirth

0.92

0.00

1.8

1.4

8.39

9.42

umol/l

—

Delayed milestone in childhood

0.96

0.00

1.2

1.4

12.80

8.32

umol/l

—

Pityriasis lichenoides chronica

0.00

0.0

1.6

—

11.44

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

2.0

—

14.22

—

Benign neoplasm: Heart

0.00

0.0

1.3

—

10.33

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.0

1.6

—

9.20

—

Benign neoplasm: Testis

0.00

0.0

2.0

—

14.71

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

2.2

—

10.83

—

Polyglandular dysfunction

0.00

0.0

1.2

—

18.40

—

Other congenital malformations of skull and face bones

0.00

0.0

1.5

—

7.83

—

Benign neoplasm: Skin, unspecified

0.96

0.00

1.0

1.5

15.82

12.78

umol/l

—

Benign neoplasm: Testis

0.00

0.0

1.4

—

13.14

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.98

0.00

1.1

1.3

9.44

9.12

umol/l

—

Moderate mental retardation

0.00

0.0

1.4

—

10.60

—

Cyst of spleen

0.00

0.0

1.4

—

10.80

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.5

—

8.67

—

Gluteal tendinitis

0.99

0.00

2.2

1.5

10.27

11.44

umol/l

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.7

—

13.57

—

Assault by hanging, strangulation and suffocation

0.00

0.0

1.8

—

9.67

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.00

0.00

1.0

1.6

9.61

11.46

umol/l

—

Tick-borne viral encephalitis

0.00

0.0

1.1

—

12.57

—

Granulosa cell carcinoma of ovary

0.00

0.0

1.3

—

12.00

—

Disorder of mineral metabolism, other/unspecified

0.00

0.0

2.2

—

15.42

—

Other mosquito-borne viral fevers

0.00

0.0

2.0

—

8.94

—

Colour vision deficiencies

0.00

0.0

1.8

—

9.25

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.0

—

10.10

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Homocysteine [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS